id	sid	tid	token	lemma	pos
ijpds-3583	1	1	shaikhmulani	shaikhmulani	INTJ
ijpds-3583	1	2	et	et	PROPN
ijpds-3583	1	3	al	al	PROPN
ijpds-3583	1	4	.	.	PROPN
ijpds-3583	2	1	rp	rp	NOUN
ijpds-3583	2	2	-	-	PUNCT
ijpds-3583	2	3	hplc	hplc	NOUN
ijpds-3583	2	4	method	method	NOUN
ijpds-3583	2	5	development	development	NOUN
ijpds-3583	2	6	and	and	CCONJ
ijpds-3583	2	7	validation	validation	NOUN
ijpds-3583	2	8	of	of	ADP
ijpds-3583	2	9	ben.hcl	ben.hcl	PROPN
ijpds-3583	2	10	&	&	CCONJ
ijpds-3583	2	11	ctd	ctd	PROPN
ijpds-3583	2	12	vol	vol	NOUN
ijpds-3583	2	13	1	1	NUM
ijpds-3583	2	14	|	|	NOUN
ijpds-3583	2	15	issue	issue	NOUN
ijpds-3583	2	16	3	3	NUM
ijpds-3583	2	17	|	|	ADV
ijpds-3583	2	18	oct	oct	PROPN
ijpds-3583	2	19	apr	apr	PROPN
ijpds-3583	2	20	2022	2022	NUM
ijpds-3583	2	21	indian	indian	PROPN
ijpds-3583	2	22	j	j	PROPN
ijpds-3583	2	23	pharm	pharm	PROPN
ijpds-3583	2	24	drug	drug	PROPN
ijpds-3583	2	25	studies	study	NOUN
ijpds-3583	2	26	|	|	ADV
ijpds-3583	2	27	102	102	NUM
ijpds-3583	2	28	original	original	ADJ
ijpds-3583	2	29	article	article	NOUN
ijpds-3583	2	30	rp	rp	NOUN
ijpds-3583	2	31	-	-	PUNCT
ijpds-3583	2	32	hplc	hplc	NOUN
ijpds-3583	2	33	method	method	NOUN
ijpds-3583	2	34	development	development	NOUN
ijpds-3583	2	35	and	and	CCONJ
ijpds-3583	2	36	validation	validation	NOUN
ijpds-3583	2	37	for	for	ADP
ijpds-3583	2	38	simultaneous	simultaneous	ADJ
ijpds-3583	2	39	estimation	estimation	NOUN
ijpds-3583	2	40	of	of	ADP
ijpds-3583	2	41	benidipine	benidipine	NOUN
ijpds-3583	2	42	hydrochloride	hydrochloride	NOUN
ijpds-3583	2	43	and	and	CCONJ
ijpds-3583	2	44	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	2	45	in	in	ADP
ijpds-3583	2	46	pharmaceutical	pharmaceutical	ADJ
ijpds-3583	2	47	dosage	dosage	NOUN
ijpds-3583	2	48	form	form	NOUN
ijpds-3583	2	49	hasan	hasan	PROPN
ijpds-3583	2	50	i	i	PRON
ijpds-3583	2	51	shaikhmulani	shaikhmulani	VERB
ijpds-3583	2	52	,	,	PUNCT
ijpds-3583	2	53	ashpak	ashpak	PROPN
ijpds-3583	2	54	m	m	PROPN
ijpds-3583	2	55	tamboli	tamboli	NOUN
ijpds-3583	2	56	,	,	PUNCT
ijpds-3583	2	57	naziya	naziya	NOUN
ijpds-3583	2	58	a	a	DET
ijpds-3583	2	59	tamboli	tamboli	NOUN
ijpds-3583	2	60	,	,	PUNCT
ijpds-3583	2	61	rohan	rohan	PROPN
ijpds-3583	2	62	t	t	PROPN
ijpds-3583	2	63	kshirsagar	kshirsagar	PROPN
ijpds-3583	2	64	,	,	PUNCT
ijpds-3583	2	65	harshvardhan	harshvardhan	PROPN
ijpds-3583	2	66	t	t	PROPN
ijpds-3583	2	67	suryawanshi	suryawanshi	NOUN
ijpds-3583	2	68	,	,	PUNCT
ijpds-3583	2	69	omkar	omkar	NOUN
ijpds-3583	2	70	khandare	khandare	VERB
ijpds-3583	2	71	from	from	ADP
ijpds-3583	2	72	,	,	PUNCT
ijpds-3583	2	73	department	department	NOUN
ijpds-3583	2	74	of	of	ADP
ijpds-3583	2	75	pharmaceutical	pharmaceutical	ADJ
ijpds-3583	2	76	chemistry	chemistry	NOUN
ijpds-3583	2	77	,	,	PUNCT
ijpds-3583	2	78	sahyadri	sahyadri	ADJ
ijpds-3583	2	79	college	college	PROPN
ijpds-3583	2	80	of	of	ADP
ijpds-3583	2	81	pharmacy	pharmacy	NOUN
ijpds-3583	2	82	,	,	PUNCT
ijpds-3583	2	83	sangola	sangola	PROPN
ijpds-3583	2	84	,	,	PUNCT
ijpds-3583	2	85	solapur	solapur	PROPN
ijpds-3583	2	86	,	,	PUNCT
ijpds-3583	2	87	maharashtra	maharashtra	PROPN
ijpds-3583	2	88	,	,	PUNCT
ijpds-3583	2	89	india	india	PROPN
ijpds-3583	2	90	correspondence	correspondence	NOUN
ijpds-3583	2	91	to	to	ADP
ijpds-3583	2	92	:	:	PUNCT
ijpds-3583	2	93	hasan	hasan	PROPN
ijpds-3583	2	94	i	i	PRON
ijpds-3583	2	95	shaikhmulani	shaikhmulani	PROPN
ijpds-3583	2	96	,	,	PUNCT
ijpds-3583	2	97	department	department	NOUN
ijpds-3583	2	98	of	of	ADP
ijpds-3583	2	99	pharmaceutical	pharmaceutical	ADJ
ijpds-3583	2	100	chemistry	chemistry	NOUN
ijpds-3583	2	101	,	,	PUNCT
ijpds-3583	2	102	sahyadri	sahyadri	ADJ
ijpds-3583	2	103	college	college	PROPN
ijpds-3583	2	104	of	of	ADP
ijpds-3583	2	105	pharmacy	pharmacy	NOUN
ijpds-3583	2	106	,	,	PUNCT
ijpds-3583	2	107	methwade	methwade	PROPN
ijpds-3583	2	108	,	,	PUNCT
ijpds-3583	2	109	sangola	sangola	PROPN
ijpds-3583	2	110	,	,	PUNCT
ijpds-3583	2	111	solapur	solapur	PROPN
ijpds-3583	2	112	,	,	PUNCT
ijpds-3583	2	113	maharashtra	maharashtra	PROPN
ijpds-3583	2	114	,	,	PUNCT
ijpds-3583	2	115	india	india	PROPN
ijpds-3583	2	116	413307	413307	NUM
ijpds-3583	2	117	email	email	NOUN
ijpds-3583	2	118	:	:	PUNCT
ijpds-3583	2	119	shaikhmulani9881@gmail.com	shaikhmulani9881@gmail.com	X
ijpds-3583	2	120	abstract	abstract	ADJ
ijpds-3583	2	121	a	a	DET
ijpds-3583	2	122	simple	simple	ADJ
ijpds-3583	2	123	,	,	PUNCT
ijpds-3583	2	124	precise	precise	ADJ
ijpds-3583	2	125	,	,	PUNCT
ijpds-3583	2	126	rapid	rapid	ADJ
ijpds-3583	2	127	and	and	CCONJ
ijpds-3583	2	128	accurate	accurate	ADJ
ijpds-3583	2	129	reverse	reverse	NOUN
ijpds-3583	2	130	phase	phase	NOUN
ijpds-3583	2	131	high	high	ADJ
ijpds-3583	2	132	performance	performance	NOUN
ijpds-3583	2	133	liquid	liquid	NOUN
ijpds-3583	2	134	chromatography	chromatography	NOUN
ijpds-3583	2	135	(	(	PUNCT
ijpds-3583	2	136	hplc	hplc	NOUN
ijpds-3583	2	137	)	)	PUNCT
ijpds-3583	2	138	method	method	NOUN
ijpds-3583	2	139	was	be	AUX
ijpds-3583	2	140	developed	develop	VERB
ijpds-3583	2	141	for	for	ADP
ijpds-3583	2	142	the	the	DET
ijpds-3583	2	143	estimation	estimation	NOUN
ijpds-3583	2	144	of	of	ADP
ijpds-3583	2	145	benidipine	benidipine	NOUN
ijpds-3583	2	146	hydrochloride	hydrochloride	NOUN
ijpds-3583	2	147	and	and	CCONJ
ijpds-3583	2	148	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	2	149	in	in	ADP
ijpds-3583	2	150	bulk	bulk	NOUN
ijpds-3583	2	151	and	and	CCONJ
ijpds-3583	2	152	tablet	tablet	ADJ
ijpds-3583	2	153	dosage	dosage	NOUN
ijpds-3583	2	154	form	form	NOUN
ijpds-3583	2	155	.	.	PUNCT
ijpds-3583	3	1	c18	c18	PROPN
ijpds-3583	3	2	c-18	c-18	PROPN
ijpds-3583	3	3	agilent	agilent	PROPN
ijpds-3583	3	4	zorbax	zorbax	PROPN
ijpds-3583	3	5	bonus	bonus	PROPN
ijpds-3583	3	6	–	–	PUNCT
ijpds-3583	3	7	rp	rp	NOUN
ijpds-3583	3	8	(	(	PUNCT
ijpds-3583	3	9	250	250	NUM
ijpds-3583	3	10	x	x	SYM
ijpds-3583	3	11	4.6	4.6	NUM
ijpds-3583	3	12	mm	mm	NOUN
ijpds-3583	3	13	,	,	PUNCT
ijpds-3583	3	14	particle	particle	NOUN
ijpds-3583	3	15	size	size	NOUN
ijpds-3583	3	16	-5	-5	PUNCT
ijpds-3583	3	17	micron	micron	NOUN
ijpds-3583	3	18	)	)	PUNCT
ijpds-3583	3	19	was	be	AUX
ijpds-3583	3	20	used	use	VERB
ijpds-3583	3	21	in	in	ADP
ijpds-3583	3	22	this	this	DET
ijpds-3583	3	23	method	method	NOUN
ijpds-3583	3	24	.	.	PUNCT
ijpds-3583	4	1	the	the	DET
ijpds-3583	4	2	mobile	mobile	ADJ
ijpds-3583	4	3	phase	phase	NOUN
ijpds-3583	4	4	comprises	comprise	NOUN
ijpds-3583	4	5	of	of	ADP
ijpds-3583	4	6	methanol	methanol	NOUN
ijpds-3583	4	7	and	and	CCONJ
ijpds-3583	4	8	0.1	0.1	NUM
ijpds-3583	4	9	%	%	NOUN
ijpds-3583	4	10	orthophosphoric	orthophosphoric	ADJ
ijpds-3583	4	11	acid	acid	NOUN
ijpds-3583	4	12	(	(	PUNCT
ijpds-3583	4	13	45:55v	45:55v	NUM
ijpds-3583	4	14	/	/	SYM
ijpds-3583	4	15	v	v	NOUN
ijpds-3583	4	16	)	)	PUNCT
ijpds-3583	4	17	with	with	ADP
ijpds-3583	4	18	flow	flow	NOUN
ijpds-3583	4	19	rate	rate	NOUN
ijpds-3583	4	20	1	1	NUM
ijpds-3583	4	21	ml	ml	NOUN
ijpds-3583	4	22	/	/	SYM
ijpds-3583	4	23	min	min	NOUN
ijpds-3583	4	24	(	(	PUNCT
ijpds-3583	4	25	photodiode	photodiode	NOUN
ijpds-3583	4	26	array	array	NOUN
ijpds-3583	4	27	detector	detector	NOUN
ijpds-3583	4	28	)	)	PUNCT
ijpds-3583	4	29	.	.	PUNCT
ijpds-3583	5	1	the	the	DET
ijpds-3583	5	2	retention	retention	NOUN
ijpds-3583	5	3	time	time	NOUN
ijpds-3583	5	4	for	for	ADP
ijpds-3583	5	5	benidipine	benidipine	NOUN
ijpds-3583	5	6	hydrochloride	hydrochloride	NOUN
ijpds-3583	5	7	was	be	AUX
ijpds-3583	5	8	1.09	1.09	NUM
ijpds-3583	5	9	min	min	NOUN
ijpds-3583	5	10	and	and	CCONJ
ijpds-3583	5	11	for	for	ADP
ijpds-3583	5	12	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	5	13	was	be	AUX
ijpds-3583	5	14	3.52	3.52	NUM
ijpds-3583	5	15	min	min	NOUN
ijpds-3583	5	16	.	.	PUNCT
ijpds-3583	6	1	the	the	DET
ijpds-3583	6	2	detection	detection	NOUN
ijpds-3583	6	3	concentration	concentration	NOUN
ijpds-3583	6	4	was	be	AUX
ijpds-3583	6	5	linear	linear	ADJ
ijpds-3583	6	6	over	over	ADP
ijpds-3583	6	7	32	32	NUM
ijpds-3583	6	8	-	-	SYM
ijpds-3583	6	9	48	48	NUM
ijpds-3583	6	10	µg	µg	NOUN
ijpds-3583	6	11	/	/	SYM
ijpds-3583	6	12	ml	ml	NOUN
ijpds-3583	6	13	for	for	ADP
ijpds-3583	6	14	benidipine	benidipine	NOUN
ijpds-3583	6	15	hydrochloride	hydrochloride	NOUN
ijpds-3583	6	16	and	and	CCONJ
ijpds-3583	6	17	100	100	NUM
ijpds-3583	6	18	-	-	SYM
ijpds-3583	6	19	150	150	NUM
ijpds-3583	6	20	µg	µg	NOUN
ijpds-3583	6	21	/	/	SYM
ijpds-3583	6	22	ml	ml	NOUN
ijpds-3583	6	23	for	for	ADP
ijpds-3583	6	24	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	6	25	.	.	PUNCT
ijpds-3583	7	1	the	the	DET
ijpds-3583	7	2	regression	regression	NOUN
ijpds-3583	7	3	equation	equation	NOUN
ijpds-3583	7	4	of	of	ADP
ijpds-3583	7	5	benidipine	benidipine	NOUN
ijpds-3583	7	6	hydrochloride	hydrochloride	NOUN
ijpds-3583	7	7	and	and	CCONJ
ijpds-3583	7	8	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	7	9	were	be	AUX
ijpds-3583	7	10	found	find	VERB
ijpds-3583	7	11	to	to	PART
ijpds-3583	7	12	be	be	AUX
ijpds-3583	7	13	y	y	PROPN
ijpds-3583	7	14	=	=	SYM
ijpds-3583	7	15	50184x30070	50184x30070	PROPN
ijpds-3583	7	16	and	and	CCONJ
ijpds-3583	7	17	y	y	NOUN
ijpds-3583	7	18	=	=	SYM
ijpds-3583	7	19	37102x-74642	37102x-74642	NUM
ijpds-3583	7	20	respectively	respectively	ADV
ijpds-3583	7	21	with	with	ADP
ijpds-3583	7	22	regression	regression	NOUN
ijpds-3583	7	23	coefficient	coefficient	NOUN
ijpds-3583	7	24	of	of	ADP
ijpds-3583	7	25	benidipine	benidipine	NOUN
ijpds-3583	7	26	hydrochloride	hydrochloride	NOUN
ijpds-3583	7	27	and	and	CCONJ
ijpds-3583	7	28	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	7	29	were	be	AUX
ijpds-3583	7	30	0.999	0.999	NUM
ijpds-3583	7	31	and	and	CCONJ
ijpds-3583	7	32	0.999	0.999	NUM
ijpds-3583	7	33	.	.	PUNCT
ijpds-3583	8	1	so	so	ADV
ijpds-3583	8	2	,	,	PUNCT
ijpds-3583	8	3	the	the	DET
ijpds-3583	8	4	present	present	ADJ
ijpds-3583	8	5	work	work	NOUN
ijpds-3583	8	6	is	be	AUX
ijpds-3583	8	7	aimed	aim	VERB
ijpds-3583	8	8	for	for	ADP
ijpds-3583	8	9	development	development	NOUN
ijpds-3583	8	10	of	of	ADP
ijpds-3583	8	11	simple	simple	ADJ
ijpds-3583	8	12	,	,	PUNCT
ijpds-3583	8	13	reproducible	reproducible	ADJ
ijpds-3583	8	14	chromatographic	chromatographic	ADJ
ijpds-3583	8	15	rp	rp	NOUN
ijpds-3583	8	16	-	-	PUNCT
ijpds-3583	8	17	hplc	hplc	NOUN
ijpds-3583	8	18	method	method	NOUN
ijpds-3583	8	19	for	for	ADP
ijpds-3583	8	20	simultaneous	simultaneous	ADJ
ijpds-3583	8	21	estimation	estimation	NOUN
ijpds-3583	8	22	of	of	ADP
ijpds-3583	8	23	benidipine	benidipine	NOUN
ijpds-3583	8	24	hydrochloride	hydrochloride	NOUN
ijpds-3583	8	25	and	and	CCONJ
ijpds-3583	8	26	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	8	27	.	.	PUNCT
ijpds-3583	9	1	the	the	DET
ijpds-3583	9	2	developed	develop	VERB
ijpds-3583	9	3	method	method	NOUN
ijpds-3583	9	4	was	be	AUX
ijpds-3583	9	5	successfully	successfully	ADV
ijpds-3583	9	6	validated	validate	VERB
ijpds-3583	9	7	in	in	ADP
ijpds-3583	9	8	accordance	accordance	NOUN
ijpds-3583	9	9	to	to	ADP
ijpds-3583	9	10	ich	ich	PROPN
ijpds-3583	9	11	guideline	guideline	NOUN
ijpds-3583	9	12	.	.	PUNCT
ijpds-3583	10	1	hence	hence	ADV
ijpds-3583	10	2	the	the	DET
ijpds-3583	10	3	method	method	NOUN
ijpds-3583	10	4	can	can	AUX
ijpds-3583	10	5	be	be	AUX
ijpds-3583	10	6	conveniently	conveniently	ADV
ijpds-3583	10	7	adopted	adopt	VERB
ijpds-3583	10	8	for	for	ADP
ijpds-3583	10	9	routine	routine	ADJ
ijpds-3583	10	10	analysis	analysis	NOUN
ijpds-3583	10	11	in	in	ADP
ijpds-3583	10	12	quality	quality	NOUN
ijpds-3583	10	13	control	control	NOUN
ijpds-3583	10	14	laboratories	laboratory	NOUN
ijpds-3583	10	15	.	.	PUNCT
ijpds-3583	11	1	key	key	ADJ
ijpds-3583	11	2	words	word	NOUN
ijpds-3583	11	3	:	:	PUNCT
ijpds-3583	11	4	benidipine	benidipine	NOUN
ijpds-3583	11	5	hydrochloride	hydrochloride	NOUN
ijpds-3583	11	6	,	,	PUNCT
ijpds-3583	11	7	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	11	8	,	,	PUNCT
ijpds-3583	11	9	rp	rp	NOUN
ijpds-3583	11	10	-	-	PUNCT
ijpds-3583	11	11	hplc	hplc	NOUN
ijpds-3583	11	12	,	,	PUNCT
ijpds-3583	11	13	method	method	NOUN
ijpds-3583	11	14	development	development	NOUN
ijpds-3583	11	15	,	,	PUNCT
ijpds-3583	11	16	validation	validation	NOUN
ijpds-3583	11	17	enidipine	enidipine	NOUN
ijpds-3583	11	18	hydrochloride	hydrochloride	NOUN
ijpds-3583	11	19	is	be	AUX
ijpds-3583	11	20	a	a	DET
ijpds-3583	11	21	5	5	NUM
ijpds-3583	11	22	-	-	PUNCT
ijpds-3583	11	23	o-[(3r)1benzylpiperidin-3	o-[(3r)1benzylpiperidin-3	NOUN
ijpds-3583	11	24	-	-	PUNCT
ijpds-3583	11	25	yl	yl	NOUN
ijpds-3583	11	26	]	]	X
ijpds-3583	11	27	3	3	NUM
ijpds-3583	11	28	-	-	PUNCT
ijpds-3583	11	29	o	o	NOUN
ijpds-3583	11	30	-	-	NOUN
ijpds-3583	11	31	methyl	methyl	NOUN
ijpds-3583	11	32	(	(	PUNCT
ijpds-3583	11	33	4r)-2	4r)-2	PROPN
ijpds-3583	11	34	,	,	PUNCT
ijpds-3583	11	35	6dimethyl-4-(3	6dimethyl-4-(3	NUM
ijpds-3583	11	36	-	-	PUNCT
ijpds-3583	11	37	nitrophenyl)-1	nitrophenyl)-1	PROPN
ijpds-3583	11	38	,	,	PUNCT
ijpds-3583	11	39	4	4	NUM
ijpds-3583	11	40	-	-	PUNCT
ijpds-3583	11	41	dihydropyridine3	dihydropyridine3	NOUN
ijpds-3583	11	42	,	,	PUNCT
ijpds-3583	11	43	5dicarboxylate	5dicarboxylate	NUM
ijpds-3583	11	44	;	;	PUNCT
ijpds-3583	11	45	hydrochloride	hydrochloride	NOUN
ijpds-3583	11	46	[	[	X
ijpds-3583	11	47	1	1	NUM
ijpds-3583	11	48	-	-	SYM
ijpds-3583	11	49	2	2	NUM
ijpds-3583	11	50	]	]	PUNCT
ijpds-3583	11	51	.	.	PUNCT
ijpds-3583	12	1	benidipine	benidipine	PROPN
ijpds-3583	12	2	hydrochloride	hydrochloride	NOUN
ijpds-3583	12	3	is	be	AUX
ijpds-3583	12	4	a	a	DET
ijpds-3583	12	5	long	long	ADJ
ijpds-3583	12	6	acting	act	VERB
ijpds-3583	12	7	anti	anti	ADJ
ijpds-3583	12	8	-	-	ADJ
ijpds-3583	12	9	hypertensive	hypertensive	ADJ
ijpds-3583	12	10	drug	drug	NOUN
ijpds-3583	12	11	class	class	NOUN
ijpds-3583	12	12	of	of	ADP
ijpds-3583	12	13	ca2+channel	ca2+channel	PROPN
ijpds-3583	12	14	blocker	blocker	NOUN
ijpds-3583	12	15	(	(	PUNCT
ijpds-3583	12	16	dihydropyridine	dihydropyridine	PROPN
ijpds-3583	12	17	derivative	derivative	NOUN
ijpds-3583	12	18	)	)	PUNCT
ijpds-3583	12	19	its	its	PRON
ijpds-3583	12	20	longer	long	ADJ
ijpds-3583	12	21	duration	duration	NOUN
ijpds-3583	12	22	of	of	ADP
ijpds-3583	12	23	action	action	NOUN
ijpds-3583	12	24	to	to	PART
ijpds-3583	12	25	slow	slow	VERB
ijpds-3583	12	26	dissociation	dissociation	NOUN
ijpds-3583	12	27	from	from	ADP
ijpds-3583	12	28	the	the	DET
ijpds-3583	12	29	dhp	dhp	PROPN
ijpds-3583	12	30	receptor	receptor	NOUN
ijpds-3583	12	31	on	on	ADP
ijpds-3583	12	32	smooth	smooth	ADJ
ijpds-3583	12	33	muscle	muscle	NOUN
ijpds-3583	12	34	cell	cell	NOUN
ijpds-3583	12	35	[	[	PUNCT
ijpds-3583	12	36	3].it	3].it	NUM
ijpds-3583	12	37	is	be	AUX
ijpds-3583	12	38	a	a	DET
ijpds-3583	12	39	triple	triple	ADJ
ijpds-3583	12	40	l	l	NOUN
ijpds-3583	12	41	,	,	PUNCT
ijpds-3583	12	42	t	t	PROPN
ijpds-3583	12	43	and	and	CCONJ
ijpds-3583	12	44	n	n	PRON
ijpds-3583	12	45	channel	channel	NOUN
ijpds-3583	12	46	blocker	blocker	NOUN
ijpds-3583	12	47	for	for	ADP
ijpds-3583	12	48	treatment	treatment	NOUN
ijpds-3583	12	49	of	of	ADP
ijpds-3583	12	50	hypertension	hypertension	NOUN
ijpds-3583	12	51	and	and	CCONJ
ijpds-3583	12	52	angina	angina	PROPN
ijpds-3583	12	53	pectoris	pectoris	NOUN
ijpds-3583	12	54	mostly	mostly	ADV
ijpds-3583	12	55	used	use	VERB
ijpds-3583	12	56	in	in	ADP
ijpds-3583	12	57	japan	japan	PROPN
ijpds-3583	12	58	and	and	CCONJ
ijpds-3583	12	59	india	india	PROPN
ijpds-3583	13	1	[	[	X
ijpds-3583	13	2	1	1	NUM
ijpds-3583	13	3	-	-	SYM
ijpds-3583	13	4	3	3	NUM
ijpds-3583	13	5	]	]	PUNCT
ijpds-3583	13	6	.	.	PUNCT
ijpds-3583	14	1	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	14	2	is	be	AUX
ijpds-3583	14	3	a	a	DET
ijpds-3583	14	4	2chloro-5-(1	2chloro-5-(1	NUM
ijpds-3583	14	5	-	-	PUNCT
ijpds-3583	14	6	hydroxy-3	hydroxy-3	PROPN
ijpds-3583	14	7	-	-	PUNCT
ijpds-3583	14	8	oxo-2hisoindol-1	oxo-2hisoindol-1	NOUN
ijpds-3583	14	9	-	-	PUNCT
ijpds-3583	14	10	yl	yl	NOUN
ijpds-3583	14	11	)	)	PUNCT
ijpds-3583	14	12	benzenesulfonamide	benzenesulfonamide	NOUN
ijpds-3583	15	1	[	[	X
ijpds-3583	15	2	4	4	NUM
ijpds-3583	15	3	]	]	PUNCT
ijpds-3583	15	4	.	.	PUNCT
ijpds-3583	16	1	it	it	PRON
ijpds-3583	16	2	is	be	AUX
ijpds-3583	16	3	a	a	DET
ijpds-3583	16	4	long	long	ADV
ijpds-3583	16	5	-	-	PUNCT
ijpds-3583	16	6	acting	act	VERB
ijpds-3583	16	7	thiazide	thiazide	ADJ
ijpds-3583	16	8	,	,	PUNCT
ijpds-3583	16	9	diuretic	diuretic	ADJ
ijpds-3583	16	10	drug	drug	NOUN
ijpds-3583	16	11	used	use	VERB
ijpds-3583	16	12	in	in	ADP
ijpds-3583	16	13	treatment	treatment	NOUN
ijpds-3583	16	14	of	of	ADP
ijpds-3583	16	15	hypertension	hypertension	NOUN
ijpds-3583	16	16	and	and	CCONJ
ijpds-3583	16	17	certain	certain	ADJ
ijpds-3583	16	18	kidney	kidney	NOUN
ijpds-3583	16	19	disorder	disorder	NOUN
ijpds-3583	16	20	[	[	X
ijpds-3583	16	21	5	5	NUM
ijpds-3583	16	22	]	]	PUNCT
ijpds-3583	16	23	.	.	PUNCT
ijpds-3583	17	1	fig	fig	NOUN
ijpds-3583	17	2	.	.	PUNCT
ijpds-3583	18	1	1structure	1structure	NUM
ijpds-3583	18	2	of	of	ADP
ijpds-3583	18	3	benidipine	benidipine	NOUN
ijpds-3583	18	4	hydrochloride	hydrochloride	NOUN
ijpds-3583	18	5	molecular	molecular	ADJ
ijpds-3583	18	6	formula	formula	NOUN
ijpds-3583	18	7	:	:	PUNCT
ijpds-3583	18	8	c28h32cln3o6	c28h32cln3o6	ADJ
ijpds-3583	18	9	molecular	molecular	ADJ
ijpds-3583	18	10	weight	weight	NOUN
ijpds-3583	18	11	:	:	PUNCT
ijpds-3583	18	12	542	542	NUM
ijpds-3583	18	13	g	g	NOUN
ijpds-3583	18	14	/	/	SYM
ijpds-3583	18	15	mol	mol	NOUN
ijpds-3583	18	16	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	18	17	has	have	VERB
ijpds-3583	18	18	longest	long	ADJ
ijpds-3583	18	19	duration	duration	NOUN
ijpds-3583	18	20	of	of	ADP
ijpds-3583	18	21	action	action	NOUN
ijpds-3583	18	22	but	but	CCONJ
ijpds-3583	18	23	similar	similar	ADJ
ijpds-3583	18	24	diuretic	diuretic	ADJ
ijpds-3583	18	25	effect	effect	NOUN
ijpds-3583	18	26	at	at	ADP
ijpds-3583	18	27	maximum	maximum	ADJ
ijpds-3583	18	28	therapeutic	therapeutic	ADJ
ijpds-3583	18	29	doses	dose	NOUN
ijpds-3583	18	30	.	.	PUNCT
ijpds-3583	19	1	it	it	PRON
ijpds-3583	19	2	reduces	reduce	VERB
ijpds-3583	19	3	reabsorption	reabsorption	NOUN
ijpds-3583	19	4	of	of	ADP
ijpds-3583	19	5	sodium	sodium	NOUN
ijpds-3583	19	6	and	and	CCONJ
ijpds-3583	19	7	chloride	chloride	NOUN
ijpds-3583	19	8	primarily	primarily	ADV
ijpds-3583	19	9	through	through	ADP
ijpds-3583	19	10	inhibition	inhibition	NOUN
ijpds-3583	19	11	of	of	ADP
ijpds-3583	19	12	the	the	DET
ijpds-3583	19	13	na+	na+	NOUN
ijpds-3583	19	14	/	/	SYM
ijpds-3583	19	15	clsymporter	clsymporter	NOUN
ijpds-3583	19	16	in	in	ADP
ijpds-3583	19	17	the	the	DET
ijpds-3583	19	18	apical	apical	ADJ
ijpds-3583	19	19	membrane	membrane	NOUN
ijpds-3583	19	20	of	of	ADP
ijpds-3583	19	21	distal	distal	ADJ
ijpds-3583	19	22	convoluted	convoluted	ADJ
ijpds-3583	19	23	tubule	tubule	NOUN
ijpds-3583	19	24	cells	cell	NOUN
ijpds-3583	19	25	in	in	ADP
ijpds-3583	19	26	kidney	kidney	NOUN
ijpds-3583	19	27	[	[	X
ijpds-3583	19	28	6	6	NUM
ijpds-3583	19	29	-	-	SYM
ijpds-3583	19	30	7	7	NUM
ijpds-3583	19	31	]	]	PUNCT
ijpds-3583	19	32	.	.	PUNCT
ijpds-3583	20	1	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	20	2	was	be	AUX
ijpds-3583	20	3	first	first	ADV
ijpds-3583	20	4	introduced	introduce	VERB
ijpds-3583	20	5	in	in	ADP
ijpds-3583	20	6	switzerland	switzerland	PROPN
ijpds-3583	20	7	in1959	in1959	VERB
ijpds-3583	20	8	it	it	PRON
ijpds-3583	20	9	is	be	AUX
ijpds-3583	20	10	also	also	ADV
ijpds-3583	20	11	available	available	ADJ
ijpds-3583	20	12	as	as	ADP
ijpds-3583	20	13	generic	generic	ADJ
ijpds-3583	20	14	medicine	medicine	NOUN
ijpds-3583	21	1	[	[	X
ijpds-3583	21	2	4	4	NUM
ijpds-3583	21	3	]	]	PUNCT
ijpds-3583	21	4	.	.	PUNCT
ijpds-3583	22	1	fig	fig	NOUN
ijpds-3583	22	2	.	.	PUNCT
ijpds-3583	23	1	2	2	NUM
ijpds-3583	23	2	–	–	PUNCT
ijpds-3583	23	3	structure	structure	NOUN
ijpds-3583	23	4	of	of	ADP
ijpds-3583	23	5	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	23	6	molecular	molecular	ADJ
ijpds-3583	23	7	formula	formula	NOUN
ijpds-3583	23	8	:	:	PUNCT
ijpds-3583	23	9	c14h11cln2o4s	c14h11cln2o4s	ADJ
ijpds-3583	23	10	molecular	molecular	ADJ
ijpds-3583	23	11	weight	weight	NOUN
ijpds-3583	23	12	:	:	PUNCT
ijpds-3583	23	13	338.8g	338.8g	NUM
ijpds-3583	23	14	/	/	SYM
ijpds-3583	23	15	mol	mol	ADP
ijpds-3583	23	16	b	b	PROPN
ijpds-3583	23	17	shaikhmulani	shaikhmulani	PROPN
ijpds-3583	23	18	et	et	PROPN
ijpds-3583	23	19	al	al	PROPN
ijpds-3583	23	20	.	.	PROPN
ijpds-3583	24	1	rp	rp	NOUN
ijpds-3583	24	2	-	-	PUNCT
ijpds-3583	24	3	hplc	hplc	NOUN
ijpds-3583	24	4	method	method	NOUN
ijpds-3583	24	5	development	development	NOUN
ijpds-3583	24	6	and	and	CCONJ
ijpds-3583	24	7	validation	validation	NOUN
ijpds-3583	24	8	of	of	ADP
ijpds-3583	24	9	ben.hcl	ben.hcl	PROPN
ijpds-3583	24	10	&	&	CCONJ
ijpds-3583	24	11	ctd	ctd	PROPN
ijpds-3583	24	12	vol	vol	NOUN
ijpds-3583	24	13	1	1	NUM
ijpds-3583	24	14	|	|	NOUN
ijpds-3583	24	15	issue	issue	NOUN
ijpds-3583	24	16	3	3	NUM
ijpds-3583	24	17	|	|	ADV
ijpds-3583	24	18	oct	oct	PROPN
ijpds-3583	24	19	apr	apr	PROPN
ijpds-3583	24	20	2022	2022	NUM
ijpds-3583	24	21	indian	indian	PROPN
ijpds-3583	24	22	j	j	PROPN
ijpds-3583	24	23	pharm	pharm	PROPN
ijpds-3583	24	24	drug	drug	PROPN
ijpds-3583	24	25	studies	study	NOUN
ijpds-3583	24	26	|	|	ADV
ijpds-3583	24	27	103	103	NUM
ijpds-3583	24	28	materials	material	NOUN
ijpds-3583	24	29	and	and	CCONJ
ijpds-3583	24	30	methods	method	NOUN
ijpds-3583	24	31	chemicals	chemical	NOUN
ijpds-3583	24	32	used	use	VERB
ijpds-3583	24	33	:	:	PUNCT
ijpds-3583	24	34	a	a	DET
ijpds-3583	24	35	pure	pure	ADJ
ijpds-3583	24	36	drug	drug	NOUN
ijpds-3583	24	37	in	in	ADP
ijpds-3583	24	38	powder	powder	NOUN
ijpds-3583	24	39	form	form	NOUN
ijpds-3583	24	40	benidipine	benidipine	NOUN
ijpds-3583	24	41	hydrochloride	hydrochloride	NOUN
ijpds-3583	24	42	and	and	CCONJ
ijpds-3583	24	43	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	24	44	received	receive	VERB
ijpds-3583	24	45	from	from	ADP
ijpds-3583	24	46	alkumentis	alkumentis	PROPN
ijpds-3583	24	47	pharmaceuticals	pharmaceutical	NOUN
ijpds-3583	24	48	,	,	PUNCT
ijpds-3583	24	49	mumbai	mumbai	NOUN
ijpds-3583	24	50	and	and	CCONJ
ijpds-3583	24	51	ipaca	ipaca	PROPN
ijpds-3583	24	52	pharmaceutical	pharmaceutical	PROPN
ijpds-3583	24	53	,	,	PUNCT
ijpds-3583	24	54	pvt	pvt	PROPN
ijpds-3583	24	55	.	.	PROPN
ijpds-3583	24	56	ltd	ltd	PROPN
ijpds-3583	24	57	mumbai	mumbai	PROPN
ijpds-3583	24	58	,	,	PUNCT
ijpds-3583	24	59	methanol	methanol	NOUN
ijpds-3583	24	60	(	(	PUNCT
ijpds-3583	24	61	ar	ar	NOUN
ijpds-3583	24	62	grade	grade	NOUN
ijpds-3583	24	63	)	)	PUNCT
ijpds-3583	24	64	and	and	CCONJ
ijpds-3583	24	65	orthophosphoric	orthophosphoric	ADJ
ijpds-3583	24	66	acid	acid	NOUN
ijpds-3583	24	67	utilized	utilize	VERB
ijpds-3583	24	68	as	as	ADP
ijpds-3583	24	69	diluent	diluent	NOUN
ijpds-3583	24	70	and	and	CCONJ
ijpds-3583	24	71	received	receive	VERB
ijpds-3583	24	72	from	from	ADP
ijpds-3583	24	73	fine	fine	ADJ
ijpds-3583	24	74	chem	chem	NOUN
ijpds-3583	24	75	laboratories	laboratory	NOUN
ijpds-3583	24	76	,	,	PUNCT
ijpds-3583	24	77	mumbai	mumbai	NOUN
ijpds-3583	24	78	and	and	CCONJ
ijpds-3583	24	79	loba	loba	PROPN
ijpds-3583	24	80	chemie	chemie	PROPN
ijpds-3583	24	81	pvt	pvt	PROPN
ijpds-3583	24	82	.	.	PROPN
ijpds-3583	24	83	ltd	ltd	PROPN
ijpds-3583	24	84	.	.	PROPN
ijpds-3583	24	85	and	and	CCONJ
ijpds-3583	24	86	a	a	DET
ijpds-3583	24	87	commercial	commercial	ADJ
ijpds-3583	24	88	product	product	NOUN
ijpds-3583	24	89	manufactured	manufacture	VERB
ijpds-3583	24	90	by	by	ADP
ijpds-3583	24	91	alkumenties	alkumentie	NOUN
ijpds-3583	24	92	pharmaceuticals	pharmaceutical	NOUN
ijpds-3583	24	93	“	"	PUNCT
ijpds-3583	24	94	benitowa	benitowa	PROPN
ijpds-3583	24	95	-	-	PUNCT
ijpds-3583	24	96	ch	ch	NOUN
ijpds-3583	24	97	”	"	PUNCT
ijpds-3583	24	98	which	which	PRON
ijpds-3583	24	99	contain	contain	VERB
ijpds-3583	24	100	both	both	CCONJ
ijpds-3583	24	101	the	the	DET
ijpds-3583	24	102	benidipine	benidipine	NOUN
ijpds-3583	24	103	hydrochloride	hydrochloride	NOUN
ijpds-3583	24	104	and	and	CCONJ
ijpds-3583	24	105	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	24	106	received	receive	VERB
ijpds-3583	24	107	from	from	ADP
ijpds-3583	24	108	market	market	NOUN
ijpds-3583	24	109	.	.	PUNCT
ijpds-3583	25	1	instrument	instrument	NOUN
ijpds-3583	25	2	used	use	VERB
ijpds-3583	25	3	:	:	PUNCT
ijpds-3583	25	4	agilent	agilent	PROPN
ijpds-3583	25	5	1260	1260	NUM
ijpds-3583	25	6	infinity	infinity	NOUN
ijpds-3583	25	7	quaternary	quaternary	ADJ
ijpds-3583	25	8	hplc	hplc	NOUN
ijpds-3583	25	9	device	device	NOUN
ijpds-3583	25	10	equipped	equip	VERB
ijpds-3583	25	11	with	with	ADP
ijpds-3583	25	12	photodiode	photodiode	NOUN
ijpds-3583	25	13	array	array	NOUN
ijpds-3583	25	14	detector	detector	NOUN
ijpds-3583	25	15	and	and	CCONJ
ijpds-3583	25	16	the	the	DET
ijpds-3583	25	17	output	output	NOUN
ijpds-3583	25	18	signal	signal	NOUN
ijpds-3583	25	19	was	be	AUX
ijpds-3583	25	20	checked	check	VERB
ijpds-3583	25	21	and	and	CCONJ
ijpds-3583	25	22	processed	process	VERB
ijpds-3583	25	23	using	use	VERB
ijpds-3583	25	24	openlab	openlab	NOUN
ijpds-3583	25	25	ezchrome	ezchrome	ADJ
ijpds-3583	25	26	software	software	NOUN
ijpds-3583	25	27	.	.	PUNCT
ijpds-3583	26	1	chromatographic	chromatographic	ADJ
ijpds-3583	26	2	conditions	condition	NOUN
ijpds-3583	26	3	were	be	AUX
ijpds-3583	26	4	as	as	SCONJ
ijpds-3583	26	5	follows	follow	VERB
ijpds-3583	26	6	:	:	PUNCT
ijpds-3583	26	7	oven	oven	NOUN
ijpds-3583	26	8	temperature	temperature	NOUN
ijpds-3583	26	9	:	:	PUNCT
ijpds-3583	26	10	300	300	NUM
ijpds-3583	26	11	c	c	NOUN
ijpds-3583	26	12	,	,	PUNCT
ijpds-3583	26	13	flow	flow	NOUN
ijpds-3583	26	14	rate	rate	NOUN
ijpds-3583	26	15	was:-1ml	was:-1ml	NOUN
ijpds-3583	26	16	/	/	SYM
ijpds-3583	26	17	min	min	NOUN
ijpds-3583	26	18	,	,	PUNCT
ijpds-3583	26	19	run	run	VERB
ijpds-3583	26	20	time	time	NOUN
ijpds-3583	26	21	was	be	AUX
ijpds-3583	26	22	:	:	PUNCT
ijpds-3583	26	23	10	10	NUM
ijpds-3583	26	24	min	min	NOUN
ijpds-3583	26	25	,	,	PUNCT
ijpds-3583	26	26	injection	injection	NOUN
ijpds-3583	26	27	volume	volume	NOUN
ijpds-3583	26	28	:	:	PUNCT
ijpds-3583	26	29	10µl	10µl	ADJ
ijpds-3583	26	30	,	,	PUNCT
ijpds-3583	26	31	wavelength	wavelength	NOUN
ijpds-3583	26	32	:	:	PUNCT
ijpds-3583	26	33	-238	-238	NUM
ijpds-3583	26	34	nm	nm	NOUN
ijpds-3583	26	35	,	,	PUNCT
ijpds-3583	26	36	column	column	NOUN
ijpds-3583	26	37	:	:	PUNCT
ijpds-3583	26	38	c-18agilent	c-18agilent	NOUN
ijpds-3583	26	39	zorbax	zorbax	PROPN
ijpds-3583	26	40	bonus	bonus	PROPN
ijpds-3583	26	41	–	–	PUNCT
ijpds-3583	26	42	rp	rp	NOUN
ijpds-3583	26	43	(	(	PUNCT
ijpds-3583	26	44	250	250	NUM
ijpds-3583	26	45	x	x	SYM
ijpds-3583	26	46	4.6	4.6	NUM
ijpds-3583	26	47	mm	mm	NOUN
ijpds-3583	26	48	,	,	PUNCT
ijpds-3583	26	49	particle	particle	NOUN
ijpds-3583	26	50	size	size	NOUN
ijpds-3583	26	51	-5	-5	PUNCT
ijpds-3583	26	52	micron	micron	NOUN
ijpds-3583	26	53	)	)	PUNCT
ijpds-3583	26	54	and	and	CCONJ
ijpds-3583	26	55	diluent	diluent	NOUN
ijpds-3583	26	56	:	:	PUNCT
ijpds-3583	26	57	methanol	methanol	NOUN
ijpds-3583	26	58	:	:	PUNCT
ijpds-3583	26	59	0.1	0.1	NUM
ijpds-3583	26	60	%	%	NOUN
ijpds-3583	26	61	orthophosphoric	orthophosphoric	ADJ
ijpds-3583	26	62	acid	acid	NOUN
ijpds-3583	26	63	(	(	PUNCT
ijpds-3583	26	64	50:50	50:50	NUM
ijpds-3583	26	65	)	)	PUNCT
ijpds-3583	26	66	.	.	PUNCT
ijpds-3583	27	1	preparation	preparation	NOUN
ijpds-3583	27	2	of	of	ADP
ijpds-3583	27	3	mobile	mobile	ADJ
ijpds-3583	27	4	phase	phase	NOUN
ijpds-3583	27	5	:	:	PUNCT
ijpds-3583	27	6	the	the	DET
ijpds-3583	27	7	mobile	mobile	ADJ
ijpds-3583	27	8	phase	phase	NOUN
ijpds-3583	27	9	was	be	AUX
ijpds-3583	27	10	prepared	prepare	VERB
ijpds-3583	27	11	by	by	ADP
ijpds-3583	27	12	mixing	mix	VERB
ijpds-3583	27	13	methanol	methanol	NOUN
ijpds-3583	27	14	and	and	CCONJ
ijpds-3583	27	15	0.1	0.1	NUM
ijpds-3583	27	16	%	%	NOUN
ijpds-3583	27	17	orthophosphoric	orthophosphoric	ADJ
ijpds-3583	27	18	acid	acid	NOUN
ijpds-3583	27	19	in	in	ADP
ijpds-3583	27	20	the	the	DET
ijpds-3583	27	21	ratio	ratio	NOUN
ijpds-3583	27	22	of	of	ADP
ijpds-3583	27	23	55:45	55:45	NUM
ijpds-3583	27	24	(	(	PUNCT
ijpds-3583	27	25	v	v	NOUN
ijpds-3583	27	26	/	/	SYM
ijpds-3583	27	27	v	v	NOUN
ijpds-3583	27	28	)	)	PUNCT
ijpds-3583	27	29	.	.	PUNCT
ijpds-3583	28	1	the	the	DET
ijpds-3583	28	2	resultant	resultant	NOUN
ijpds-3583	28	3	solution	solution	NOUN
ijpds-3583	28	4	filtered	filter	VERB
ijpds-3583	28	5	through	through	ADP
ijpds-3583	28	6	micron	micron	NOUN
ijpds-3583	28	7	filter	filter	NOUN
ijpds-3583	28	8	0.45	0.45	NUM
ijpds-3583	28	9	µm	µm	ADP
ijpds-3583	28	10	pore	pore	ADJ
ijpds-3583	28	11	size	size	NOUN
ijpds-3583	28	12	by	by	ADP
ijpds-3583	28	13	means	mean	NOUN
ijpds-3583	28	14	of	of	ADP
ijpds-3583	28	15	vacuum	vacuum	NOUN
ijpds-3583	28	16	pump	pump	NOUN
ijpds-3583	28	17	and	and	CCONJ
ijpds-3583	28	18	then	then	ADV
ijpds-3583	28	19	degassed	degas	VERB
ijpds-3583	28	20	by	by	ADP
ijpds-3583	28	21	using	use	VERB
ijpds-3583	28	22	ultasonicator	ultasonicator	NOUN
ijpds-3583	28	23	to	to	PART
ijpds-3583	28	24	remove	remove	VERB
ijpds-3583	28	25	gases	gas	NOUN
ijpds-3583	28	26	in	in	ADP
ijpds-3583	28	27	solvent	solvent	NOUN
ijpds-3583	28	28	.	.	PUNCT
ijpds-3583	29	1	preparation	preparation	NOUN
ijpds-3583	29	2	of	of	ADP
ijpds-3583	29	3	standard	standard	ADJ
ijpds-3583	29	4	solution	solution	NOUN
ijpds-3583	29	5	:	:	PUNCT
ijpds-3583	29	6	standard	standard	ADJ
ijpds-3583	29	7	solution	solution	NOUN
ijpds-3583	29	8	of	of	ADP
ijpds-3583	29	9	both	both	CCONJ
ijpds-3583	29	10	the	the	DET
ijpds-3583	29	11	drug	drug	NOUN
ijpds-3583	29	12	were	be	AUX
ijpds-3583	29	13	prepared	prepare	VERB
ijpds-3583	29	14	by	by	ADP
ijpds-3583	29	15	weighing	weigh	VERB
ijpds-3583	29	16	5	5	NUM
ijpds-3583	29	17	mg	mg	NUM
ijpds-3583	29	18	and	and	CCONJ
ijpds-3583	29	19	12.5	12.5	NUM
ijpds-3583	29	20	mg	mg	NOUN
ijpds-3583	29	21	of	of	ADP
ijpds-3583	29	22	benidipine	benidipine	NOUN
ijpds-3583	29	23	hydrochloride	hydrochloride	NOUN
ijpds-3583	29	24	&	&	CCONJ
ijpds-3583	29	25	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	29	26	and	and	CCONJ
ijpds-3583	29	27	transfer	transfer	NOUN
ijpds-3583	29	28	in	in	ADP
ijpds-3583	29	29	to	to	ADP
ijpds-3583	29	30	10ml	10ml	NOUN
ijpds-3583	29	31	of	of	ADP
ijpds-3583	29	32	volumetric	volumetric	ADJ
ijpds-3583	29	33	flask	flask	NOUN
ijpds-3583	29	34	and	and	CCONJ
ijpds-3583	29	35	make	make	VERB
ijpds-3583	29	36	volume	volume	NOUN
ijpds-3583	29	37	up	up	ADP
ijpds-3583	29	38	to	to	ADP
ijpds-3583	29	39	10ml	10ml	NOUN
ijpds-3583	29	40	using	use	VERB
ijpds-3583	29	41	mobile	mobile	ADJ
ijpds-3583	29	42	phase	phase	NOUN
ijpds-3583	29	43	and	and	CCONJ
ijpds-3583	29	44	prepared	prepared	ADJ
ijpds-3583	29	45	solutions	solution	NOUN
ijpds-3583	29	46	concentration	concentration	NOUN
ijpds-3583	29	47	were	be	AUX
ijpds-3583	29	48	500µg	500µg	NOUN
ijpds-3583	29	49	/	/	SYM
ijpds-3583	29	50	ml	ml	NOUN
ijpds-3583	29	51	and	and	CCONJ
ijpds-3583	29	52	1250	1250	NUM
ijpds-3583	29	53	µg	µg	NOUN
ijpds-3583	29	54	/	/	SYM
ijpds-3583	29	55	ml	ml	X
ijpds-3583	29	56	respectively	respectively	ADV
ijpds-3583	29	57	.	.	PUNCT
ijpds-3583	30	1	preparation	preparation	NOUN
ijpds-3583	30	2	of	of	ADP
ijpds-3583	30	3	working	work	VERB
ijpds-3583	30	4	standard	standard	ADJ
ijpds-3583	30	5	solution	solution	NOUN
ijpds-3583	30	6	:	:	PUNCT
ijpds-3583	30	7	the	the	DET
ijpds-3583	30	8	working	work	VERB
ijpds-3583	30	9	standard	standard	ADJ
ijpds-3583	30	10	solution	solution	NOUN
ijpds-3583	30	11	of	of	ADP
ijpds-3583	30	12	both	both	CCONJ
ijpds-3583	30	13	the	the	DET
ijpds-3583	30	14	drug	drug	NOUN
ijpds-3583	30	15	were	be	AUX
ijpds-3583	30	16	prepared	prepare	VERB
ijpds-3583	30	17	by	by	ADP
ijpds-3583	30	18	weighing	weigh	VERB
ijpds-3583	30	19	5	5	NUM
ijpds-3583	30	20	mg	mg	NUM
ijpds-3583	30	21	and	and	CCONJ
ijpds-3583	30	22	12.5	12.5	NUM
ijpds-3583	30	23	mg	mg	NOUN
ijpds-3583	30	24	of	of	ADP
ijpds-3583	30	25	benidipine	benidipine	NOUN
ijpds-3583	30	26	hydrochloride	hydrochloride	NOUN
ijpds-3583	30	27	&	&	CCONJ
ijpds-3583	30	28	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	30	29	and	and	CCONJ
ijpds-3583	30	30	transfer	transfer	NOUN
ijpds-3583	30	31	in	in	ADP
ijpds-3583	30	32	to	to	ADP
ijpds-3583	30	33	10ml	10ml	NOUN
ijpds-3583	30	34	of	of	ADP
ijpds-3583	30	35	volumetric	volumetric	ADJ
ijpds-3583	30	36	flask	flask	NOUN
ijpds-3583	30	37	and	and	CCONJ
ijpds-3583	30	38	make	make	VERB
ijpds-3583	30	39	volume	volume	NOUN
ijpds-3583	30	40	up	up	ADP
ijpds-3583	30	41	to	to	ADP
ijpds-3583	30	42	10ml	10ml	NOUN
ijpds-3583	30	43	using	use	VERB
ijpds-3583	30	44	mobile	mobile	ADJ
ijpds-3583	30	45	phase	phase	NOUN
ijpds-3583	30	46	then	then	ADV
ijpds-3583	30	47	pipette	pipette	VERB
ijpds-3583	30	48	out	out	ADP
ijpds-3583	30	49	0.8ml	0.8ml	PROPN
ijpds-3583	30	50	and	and	CCONJ
ijpds-3583	30	51	1.0ml	1.0ml	NUM
ijpds-3583	30	52	respectively	respectively	ADV
ijpds-3583	30	53	and	and	CCONJ
ijpds-3583	30	54	add	add	VERB
ijpds-3583	30	55	into	into	ADP
ijpds-3583	30	56	another	another	DET
ijpds-3583	30	57	10ml	10ml	ADJ
ijpds-3583	30	58	volumetric	volumetric	NOUN
ijpds-3583	30	59	flask	flask	NOUN
ijpds-3583	30	60	and	and	CCONJ
ijpds-3583	30	61	make	make	VERB
ijpds-3583	30	62	up	up	ADP
ijpds-3583	30	63	volume	volume	NOUN
ijpds-3583	30	64	up	up	ADP
ijpds-3583	30	65	to	to	ADP
ijpds-3583	30	66	10ml	10ml	NOUN
ijpds-3583	30	67	using	use	VERB
ijpds-3583	30	68	mobile	mobile	ADJ
ijpds-3583	30	69	phase	phase	NOUN
ijpds-3583	30	70	.	.	PUNCT
ijpds-3583	31	1	the	the	DET
ijpds-3583	31	2	resultant	resultant	NOUN
ijpds-3583	31	3	solution	solution	NOUN
ijpds-3583	31	4	was	be	AUX
ijpds-3583	31	5	40µg	40µg	ADJ
ijpds-3583	31	6	/	/	SYM
ijpds-3583	31	7	ml	ml	NOUN
ijpds-3583	31	8	and	and	CCONJ
ijpds-3583	31	9	125µg	125µg	NOUN
ijpds-3583	31	10	/	/	SYM
ijpds-3583	31	11	ml	ml	NOUN
ijpds-3583	31	12	,	,	PUNCT
ijpds-3583	31	13	respectively	respectively	ADV
ijpds-3583	31	14	.	.	PUNCT
ijpds-3583	32	1	selection	selection	NOUN
ijpds-3583	32	2	of	of	ADP
ijpds-3583	32	3	wavelength	wavelength	NOUN
ijpds-3583	32	4	:	:	PUNCT
ijpds-3583	32	5	the	the	DET
ijpds-3583	32	6	sample	sample	NOUN
ijpds-3583	32	7	was	be	AUX
ijpds-3583	32	8	scanned	scan	VERB
ijpds-3583	32	9	from	from	ADP
ijpds-3583	32	10	200400	200400	NUM
ijpds-3583	32	11	nm	nm	PRON
ijpds-3583	32	12	photodiode	photodiode	NOUN
ijpds-3583	32	13	array	array	NOUN
ijpds-3583	32	14	detectors	detector	NOUN
ijpds-3583	32	15	.	.	PUNCT
ijpds-3583	33	1	the	the	DET
ijpds-3583	33	2	wavelength	wavelength	NOUN
ijpds-3583	33	3	selected	select	VERB
ijpds-3583	33	4	for	for	ADP
ijpds-3583	33	5	analysis	analysis	NOUN
ijpds-3583	33	6	chosen	choose	VERB
ijpds-3583	33	7	was	be	AUX
ijpds-3583	33	8	238	238	NUM
ijpds-3583	33	9	nm	nm	NOUN
ijpds-3583	33	10	on	on	ADP
ijpds-3583	33	11	basis	basis	NOUN
ijpds-3583	33	12	of	of	ADP
ijpds-3583	33	13	appropriate	appropriate	ADJ
ijpds-3583	33	14	intensity	intensity	NOUN
ijpds-3583	33	15	of	of	ADP
ijpds-3583	33	16	both	both	CCONJ
ijpds-3583	33	17	the	the	DET
ijpds-3583	33	18	drug	drug	NOUN
ijpds-3583	33	19	.	.	PUNCT
ijpds-3583	34	1	analysis	analysis	NOUN
ijpds-3583	34	2	of	of	ADP
ijpds-3583	34	3	marketed	market	VERB
ijpds-3583	34	4	formulation	formulation	NOUN
ijpds-3583	34	5	take	take	VERB
ijpds-3583	34	6	5	5	NUM
ijpds-3583	34	7	tablets	tablet	NOUN
ijpds-3583	34	8	each	each	DET
ijpds-3583	34	9	tablet	tablet	NOUN
ijpds-3583	34	10	contains	contain	VERB
ijpds-3583	34	11	8	8	NUM
ijpds-3583	34	12	mg	mg	NOUN
ijpds-3583	34	13	of	of	ADP
ijpds-3583	34	14	benidipine	benidipine	NOUN
ijpds-3583	34	15	hydrochloride	hydrochloride	NOUN
ijpds-3583	34	16	and	and	CCONJ
ijpds-3583	34	17	12.5	12.5	NUM
ijpds-3583	34	18	mg	mg	NOUN
ijpds-3583	34	19	of	of	ADP
ijpds-3583	34	20	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	34	21	and	and	CCONJ
ijpds-3583	34	22	weighed	weigh	VERB
ijpds-3583	34	23	and	and	CCONJ
ijpds-3583	34	24	powdered	powder	VERB
ijpds-3583	34	25	from	from	ADP
ijpds-3583	34	26	that	that	DET
ijpds-3583	34	27	transfer	transfer	NOUN
ijpds-3583	34	28	5	5	NUM
ijpds-3583	34	29	mg	mg	NOUN
ijpds-3583	34	30	of	of	ADP
ijpds-3583	34	31	benidipine	benidipine	NOUN
ijpds-3583	34	32	hydrochloride	hydrochloride	NOUN
ijpds-3583	34	33	and	and	CCONJ
ijpds-3583	34	34	12.5	12.5	NUM
ijpds-3583	34	35	mg	mg	NOUN
ijpds-3583	34	36	of	of	ADP
ijpds-3583	34	37	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	34	38	in	in	ADP
ijpds-3583	34	39	10	10	NUM
ijpds-3583	34	40	ml	ml	NOUN
ijpds-3583	34	41	of	of	ADP
ijpds-3583	34	42	volumetric	volumetric	NOUN
ijpds-3583	34	43	flask	flask	NOUN
ijpds-3583	34	44	and	and	CCONJ
ijpds-3583	34	45	make	make	VERB
ijpds-3583	34	46	up	up	ADP
ijpds-3583	34	47	volume	volume	NOUN
ijpds-3583	34	48	up	up	ADP
ijpds-3583	34	49	to	to	PART
ijpds-3583	34	50	10	10	NUM
ijpds-3583	34	51	ml	ml	NOUN
ijpds-3583	34	52	with	with	ADP
ijpds-3583	34	53	help	help	NOUN
ijpds-3583	34	54	of	of	ADP
ijpds-3583	34	55	diluent	diluent	NOUN
ijpds-3583	34	56	and	and	CCONJ
ijpds-3583	34	57	further	further	ADJ
ijpds-3583	34	58	dilution	dilution	NOUN
ijpds-3583	34	59	would	would	AUX
ijpds-3583	34	60	make	make	VERB
ijpds-3583	34	61	final	final	ADJ
ijpds-3583	34	62	concentration	concentration	NOUN
ijpds-3583	34	63	of	of	ADP
ijpds-3583	34	64	solution	solution	NOUN
ijpds-3583	34	65	were	be	AUX
ijpds-3583	34	66	40µg	40µg	ADJ
ijpds-3583	34	67	/	/	SYM
ijpds-3583	34	68	ml	ml	NOUN
ijpds-3583	34	69	and	and	CCONJ
ijpds-3583	34	70	125	125	NUM
ijpds-3583	34	71	µg	µg	NOUN
ijpds-3583	34	72	/	/	SYM
ijpds-3583	34	73	ml	ml	NOUN
ijpds-3583	34	74	respectively	respectively	ADV
ijpds-3583	34	75	.	.	PUNCT
ijpds-3583	35	1	then	then	ADV
ijpds-3583	35	2	solution	solution	NOUN
ijpds-3583	35	3	was	be	AUX
ijpds-3583	35	4	filtered	filter	VERB
ijpds-3583	35	5	by	by	ADP
ijpds-3583	35	6	0.45	0.45	NUM
ijpds-3583	35	7	µm	µm	ADP
ijpds-3583	35	8	nylon	nylon	NOUN
ijpds-3583	35	9	membrane	membrane	NOUN
ijpds-3583	35	10	filter	filter	NOUN
ijpds-3583	35	11	by	by	ADP
ijpds-3583	35	12	using	use	VERB
ijpds-3583	35	13	vacuum	vacuum	NOUN
ijpds-3583	35	14	filter	filter	NOUN
ijpds-3583	35	15	.	.	PUNCT
ijpds-3583	36	1	tablet	tablet	NOUN
ijpds-3583	36	2	formulation	formulation	NOUN
ijpds-3583	36	3	analysis	analysis	NOUN
ijpds-3583	36	4	was	be	AUX
ijpds-3583	36	5	carried	carry	VERB
ijpds-3583	36	6	out	out	ADP
ijpds-3583	36	7	as	as	SCONJ
ijpds-3583	36	8	mentioned	mention	VERB
ijpds-3583	36	9	under	under	ADP
ijpds-3583	36	10	section	section	NOUN
ijpds-3583	36	11	tablet	tablet	NOUN
ijpds-3583	36	12	formulation	formulation	NOUN
ijpds-3583	36	13	analysis	analysis	NOUN
ijpds-3583	36	14	.	.	PUNCT
ijpds-3583	37	1	procedure	procedure	NOUN
ijpds-3583	37	2	was	be	AUX
ijpds-3583	37	3	repeated	repeat	VERB
ijpds-3583	37	4	for	for	ADP
ijpds-3583	37	5	5	5	NUM
ijpds-3583	37	6	times	time	NOUN
ijpds-3583	37	7	.	.	PUNCT
ijpds-3583	38	1	sample	sample	NOUN
ijpds-3583	38	2	solution	solution	NOUN
ijpds-3583	38	3	was	be	AUX
ijpds-3583	38	4	injected	inject	VERB
ijpds-3583	38	5	and	and	CCONJ
ijpds-3583	38	6	area	area	NOUN
ijpds-3583	38	7	was	be	AUX
ijpds-3583	38	8	recorded	record	VERB
ijpds-3583	38	9	for	for	ADP
ijpds-3583	38	10	each	each	DET
ijpds-3583	38	11	drug	drug	NOUN
ijpds-3583	38	12	concentration	concentration	NOUN
ijpds-3583	38	13	and	and	CCONJ
ijpds-3583	38	14	percentage	percentage	NOUN
ijpds-3583	38	15	purity	purity	NOUN
ijpds-3583	38	16	was	be	AUX
ijpds-3583	38	17	determined	determine	VERB
ijpds-3583	38	18	as	as	SCONJ
ijpds-3583	38	19	shown	show	VERB
ijpds-3583	38	20	in	in	ADP
ijpds-3583	38	21	table	table	NOUN
ijpds-3583	38	22	1	1	NUM
ijpds-3583	38	23	.	.	PUNCT
ijpds-3583	39	1	analysis	analysis	NOUN
ijpds-3583	39	2	is	be	AUX
ijpds-3583	39	3	the	the	DET
ijpds-3583	39	4	most	most	ADV
ijpds-3583	39	5	important	important	ADJ
ijpds-3583	39	6	aspect	aspect	NOUN
ijpds-3583	39	7	of	of	ADP
ijpds-3583	39	8	any	any	DET
ijpds-3583	39	9	drug	drug	NOUN
ijpds-3583	39	10	development	development	NOUN
ijpds-3583	39	11	;	;	PUNCT
ijpds-3583	39	12	a	a	DET
ijpds-3583	39	13	suitable	suitable	ADJ
ijpds-3583	39	14	method	method	NOUN
ijpds-3583	39	15	must	must	AUX
ijpds-3583	39	16	be	be	AUX
ijpds-3583	39	17	developed	develop	VERB
ijpds-3583	39	18	so	so	ADV
ijpds-3583	39	19	as	as	SCONJ
ijpds-3583	39	20	to	to	PART
ijpds-3583	39	21	ensure	ensure	VERB
ijpds-3583	39	22	that	that	SCONJ
ijpds-3583	39	23	any	any	DET
ijpds-3583	39	24	drug	drug	NOUN
ijpds-3583	39	25	in	in	ADP
ijpds-3583	39	26	dosage	dosage	NOUN
ijpds-3583	39	27	from	from	ADP
ijpds-3583	39	28	.	.	PUNCT
ijpds-3583	40	1	with	with	ADP
ijpds-3583	40	2	help	help	NOUN
ijpds-3583	40	3	of	of	ADP
ijpds-3583	40	4	method	method	NOUN
ijpds-3583	40	5	development	development	NOUN
ijpds-3583	40	6	ensure	ensure	VERB
ijpds-3583	40	7	that	that	SCONJ
ijpds-3583	40	8	the	the	DET
ijpds-3583	40	9	amount	amount	NOUN
ijpds-3583	40	10	of	of	ADP
ijpds-3583	40	11	particular	particular	ADJ
ijpds-3583	40	12	drug	drug	NOUN
ijpds-3583	40	13	can	can	AUX
ijpds-3583	40	14	easily	easily	ADV
ijpds-3583	40	15	determine	determine	VERB
ijpds-3583	40	16	.	.	PUNCT
ijpds-3583	41	1	the	the	DET
ijpds-3583	41	2	validation	validation	NOUN
ijpds-3583	41	3	parameter	parameter	NOUN
ijpds-3583	41	4	confirms	confirm	VERB
ijpds-3583	41	5	that	that	SCONJ
ijpds-3583	41	6	the	the	DET
ijpds-3583	41	7	developed	develop	VERB
ijpds-3583	41	8	method	method	NOUN
ijpds-3583	41	9	is	be	AUX
ijpds-3583	41	10	precise	precise	ADJ
ijpds-3583	41	11	,	,	PUNCT
ijpds-3583	41	12	accurate	accurate	ADJ
ijpds-3583	41	13	and	and	CCONJ
ijpds-3583	41	14	reproducible	reproducible	VERB
ijpds-3583	41	15	and	and	CCONJ
ijpds-3583	41	16	can	can	AUX
ijpds-3583	41	17	be	be	AUX
ijpds-3583	41	18	used	use	VERB
ijpds-3583	41	19	for	for	ADP
ijpds-3583	41	20	used	use	VERB
ijpds-3583	41	21	for	for	ADP
ijpds-3583	41	22	routine	routine	ADJ
ijpds-3583	41	23	evaluation	evaluation	NOUN
ijpds-3583	41	24	of	of	ADP
ijpds-3583	41	25	benidipine	benidipine	NOUN
ijpds-3583	41	26	hydrochloride	hydrochloride	NOUN
ijpds-3583	41	27	and	and	CCONJ
ijpds-3583	41	28	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	41	29	in	in	ADP
ijpds-3583	41	30	combined	combine	VERB
ijpds-3583	41	31	dosage	dosage	NOUN
ijpds-3583	41	32	form	form	NOUN
ijpds-3583	41	33	[	[	X
ijpds-3583	41	34	812	812	NUM
ijpds-3583	41	35	]	]	PUNCT
ijpds-3583	41	36	.	.	PUNCT
ijpds-3583	42	1	in	in	ADP
ijpds-3583	42	2	the	the	DET
ijpds-3583	42	3	present	present	ADJ
ijpds-3583	42	4	study	study	NOUN
ijpds-3583	42	5	suitable	suitable	ADJ
ijpds-3583	42	6	for	for	ADP
ijpds-3583	42	7	rp	rp	NOUN
ijpds-3583	42	8	-	-	PUNCT
ijpds-3583	42	9	hplc	hplc	NOUN
ijpds-3583	42	10	method	method	NOUN
ijpds-3583	42	11	was	be	AUX
ijpds-3583	42	12	developed	develop	VERB
ijpds-3583	42	13	with	with	ADP
ijpds-3583	42	14	the	the	DET
ijpds-3583	42	15	aim	aim	NOUN
ijpds-3583	42	16	of	of	ADP
ijpds-3583	42	17	making	make	VERB
ijpds-3583	42	18	detection	detection	NOUN
ijpds-3583	42	19	of	of	ADP
ijpds-3583	42	20	benidipine	benidipine	NOUN
ijpds-3583	42	21	hydrochloride	hydrochloride	NOUN
ijpds-3583	42	22	and	and	CCONJ
ijpds-3583	42	23	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	42	24	more	more	ADV
ijpds-3583	42	25	accurate	accurate	ADJ
ijpds-3583	42	26	and	and	CCONJ
ijpds-3583	42	27	precise	precise	ADJ
ijpds-3583	42	28	with	with	ADP
ijpds-3583	42	29	addition	addition	NOUN
ijpds-3583	42	30	of	of	ADP
ijpds-3583	42	31	validation	validation	NOUN
ijpds-3583	42	32	parameters	parameter	NOUN
ijpds-3583	42	33	like	like	ADP
ijpds-3583	42	34	specificity	specificity	NOUN
ijpds-3583	42	35	,	,	PUNCT
ijpds-3583	42	36	linearity	linearity	NOUN
ijpds-3583	42	37	,	,	PUNCT
ijpds-3583	42	38	accuracy	accuracy	NOUN
ijpds-3583	42	39	,	,	PUNCT
ijpds-3583	42	40	and	and	CCONJ
ijpds-3583	42	41	lod	lod	PROPN
ijpds-3583	42	42	&	&	CCONJ
ijpds-3583	42	43	loq	loq	PROPN
ijpds-3583	43	1	[	[	X
ijpds-3583	43	2	8	8	NUM
ijpds-3583	43	3	]	]	PUNCT
ijpds-3583	43	4	.	.	PUNCT
ijpds-3583	44	1	table	table	NOUN
ijpds-3583	44	2	1	1	NUM
ijpds-3583	44	3	assay	assay	NOUN
ijpds-3583	44	4	result	result	NOUN
ijpds-3583	44	5	with	with	ADP
ijpds-3583	44	6	benidipine	benidipine	NOUN
ijpds-3583	44	7	hydrochloride	hydrochloride	NOUN
ijpds-3583	44	8	&	&	CCONJ
ijpds-3583	44	9	chlorthalidone	chlorthalidone	PROPN
ijpds-3583	44	10	s.no	s.no	PROPN
ijpds-3583	44	11	benidipine	benidipine	NOUN
ijpds-3583	44	12	hydrochloride	hydrochloride	NOUN
ijpds-3583	44	13	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	44	14	peak	peak	NOUN
ijpds-3583	44	15	area	area	PROPN
ijpds-3583	44	16	amt	amt	PROPN
ijpds-3583	44	17	.	.	PUNCT
ijpds-3583	44	18	recovered	recover	VERB
ijpds-3583	44	19	in	in	ADP
ijpds-3583	44	20	µg	µg	ADV
ijpds-3583	44	21	/	/	SYM
ijpds-3583	44	22	ml	ml	NOUN
ijpds-3583	44	23	%	%	NOUN
ijpds-3583	44	24	recovery	recovery	NOUN
ijpds-3583	44	25	peak	peak	PROPN
ijpds-3583	44	26	area	area	PROPN
ijpds-3583	44	27	amt	amt	PROPN
ijpds-3583	44	28	.	.	PUNCT
ijpds-3583	45	1	recovered	recover	VERB
ijpds-3583	45	2	in	in	ADP
ijpds-3583	45	3	µg	µg	ADV
ijpds-3583	45	4	/	/	SYM
ijpds-3583	45	5	ml	ml	NOUN
ijpds-3583	45	6	%	%	NOUN
ijpds-3583	45	7	recovery	recovery	NOUN
ijpds-3583	45	8	1	1	NUM
ijpds-3583	45	9	1612593	1612593	NUM
ijpds-3583	45	10	32	32	NUM
ijpds-3583	45	11	98.54	98.54	NUM
ijpds-3583	45	12	3800032	3800032	NUM
ijpds-3583	45	13	100	100	NUM
ijpds-3583	45	14	100.41	100.41	NUM
ijpds-3583	45	15	2	2	NUM
ijpds-3583	45	16	1612895	1612895	NUM
ijpds-3583	45	17	31.97	31.97	NUM
ijpds-3583	45	18	98.56	98.56	NUM
ijpds-3583	45	19	3765482	3765482	NUM
ijpds-3583	45	20	99.81	99.81	NUM
ijpds-3583	45	21	99.67	99.67	NUM
ijpds-3583	45	22	3	3	NUM
ijpds-3583	45	23	1623583	1623583	NUM
ijpds-3583	45	24	31.82	31.82	NUM
ijpds-3583	45	25	99.22	99.22	NUM
ijpds-3583	45	26	3768221	3768221	NUM
ijpds-3583	45	27	99.98	99.98	NUM
ijpds-3583	45	28	99.57	99.57	NUM
ijpds-3583	45	29	4	4	NUM
ijpds-3583	45	30	1624896	1624896	NUM
ijpds-3583	45	31	32.03	32.03	NUM
ijpds-3583	45	32	99.31	99.31	NUM
ijpds-3583	45	33	3798523	3798523	NUM
ijpds-3583	45	34	100	100	NUM
ijpds-3583	45	35	97.67	97.67	NUM
ijpds-3583	45	36	5	5	NUM
ijpds-3583	45	37	1628369	1628369	NUM
ijpds-3583	45	38	32	32	NUM
ijpds-3583	45	39	99.52	99.52	NUM
ijpds-3583	45	40	3799213	3799213	NUM
ijpds-3583	45	41	100	100	NUM
ijpds-3583	45	42	100.39	100.39	NUM
ijpds-3583	45	43	mean	mean	NOUN
ijpds-3583	45	44	1620467	1620467	NUM
ijpds-3583	45	45	31.96	31.96	NUM
ijpds-3583	45	46	99.03	99.03	NUM
ijpds-3583	45	47	3766294	3766294	NUM
ijpds-3583	45	48	99.95	99.95	NUM
ijpds-3583	45	49	99.54	99.54	NUM
ijpds-3583	45	50	%	%	NOUN
ijpds-3583	45	51	rsd	rsd	PROPN
ijpds-3583	45	52	0.44	0.44	NUM
ijpds-3583	45	53	0.23	0.23	NUM
ijpds-3583	45	54	0.45	0.45	NUM
ijpds-3583	45	55	1.09	1.09	NUM
ijpds-3583	45	56	0.08	0.08	NUM
ijpds-3583	45	57	1.12	1.12	NUM
ijpds-3583	45	58	shaikhmulani	shaikhmulani	NOUN
ijpds-3583	45	59	et	et	PROPN
ijpds-3583	45	60	al	al	PROPN
ijpds-3583	45	61	rp	rp	PROPN
ijpds-3583	45	62	-	-	PUNCT
ijpds-3583	45	63	hplc	hplc	NOUN
ijpds-3583	45	64	method	method	NOUN
ijpds-3583	45	65	development	development	NOUN
ijpds-3583	45	66	and	and	CCONJ
ijpds-3583	45	67	validation	validation	NOUN
ijpds-3583	45	68	of	of	ADP
ijpds-3583	45	69	ben.hcl	ben.hcl	PROPN
ijpds-3583	45	70	&	&	CCONJ
ijpds-3583	45	71	ctd	ctd	PROPN
ijpds-3583	45	72	vol	vol	NOUN
ijpds-3583	45	73	1	1	NUM
ijpds-3583	45	74	|	|	NOUN
ijpds-3583	45	75	issue	issue	NOUN
ijpds-3583	45	76	3	3	NUM
ijpds-3583	45	77	|	|	ADV
ijpds-3583	45	78	oct	oct	PROPN
ijpds-3583	45	79	–	–	PUNCT
ijpds-3583	45	80	dec	dec	PROPN
ijpds-3583	45	81	2022	2022	NUM
ijpds-3583	45	82	indian	indian	PROPN
ijpds-3583	45	83	j	j	PROPN
ijpds-3583	45	84	pharm	pharm	PROPN
ijpds-3583	45	85	drug	drug	PROPN
ijpds-3583	45	86	studies	study	NOUN
ijpds-3583	45	87	|	|	ADV
ijpds-3583	45	88	104	104	NUM
ijpds-3583	45	89	table	table	NOUN
ijpds-3583	45	90	2	2	NUM
ijpds-3583	45	91	concentration	concentration	NOUN
ijpds-3583	45	92	and	and	CCONJ
ijpds-3583	45	93	area	area	NOUN
ijpds-3583	45	94	of	of	ADP
ijpds-3583	45	95	benidipine	benidipine	NOUN
ijpds-3583	45	96	hydrochloride	hydrochloride	NOUN
ijpds-3583	45	97	%	%	NOUN
ijpds-3583	45	98	level	level	NOUN
ijpds-3583	45	99	conc	conc	NOUN
ijpds-3583	45	100	(	(	PUNCT
ijpds-3583	45	101	µg	µg	NOUN
ijpds-3583	45	102	/	/	SYM
ijpds-3583	45	103	ml	ml	NOUN
ijpds-3583	45	104	)	)	PUNCT
ijpds-3583	45	105	area	area	NOUN
ijpds-3583	45	106	80	80	NUM
ijpds-3583	45	107	32	32	NUM
ijpds-3583	45	108	1584314	1584314	NUM
ijpds-3583	45	109	90	90	NUM
ijpds-3583	45	110	36	36	NUM
ijpds-3583	45	111	1762564	1762564	NUM
ijpds-3583	45	112	100	100	NUM
ijpds-3583	45	113	40	40	NUM
ijpds-3583	45	114	1979466	1979466	NUM
ijpds-3583	45	115	110	110	NUM
ijpds-3583	45	116	44	44	NUM
ijpds-3583	45	117	2181734	2181734	NUM
ijpds-3583	45	118	120	120	NUM
ijpds-3583	45	119	48	48	NUM
ijpds-3583	45	120	2378413	2378413	NUM
ijpds-3583	45	121	table	table	NOUN
ijpds-3583	45	122	3	3	NUM
ijpds-3583	45	123	concentration	concentration	NOUN
ijpds-3583	45	124	and	and	CCONJ
ijpds-3583	45	125	area	area	NOUN
ijpds-3583	45	126	of	of	ADP
ijpds-3583	45	127	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	45	128	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	45	129	%	%	NOUN
ijpds-3583	45	130	level	level	NOUN
ijpds-3583	45	131	conc	conc	NOUN
ijpds-3583	45	132	(	(	PUNCT
ijpds-3583	45	133	µg	µg	NOUN
ijpds-3583	45	134	/	/	SYM
ijpds-3583	45	135	ml	ml	NOUN
ijpds-3583	45	136	)	)	PUNCT
ijpds-3583	45	137	area	area	NOUN
ijpds-3583	45	138	80	80	NUM
ijpds-3583	45	139	100	100	NUM
ijpds-3583	45	140	3800057	3800057	NUM
ijpds-3583	45	141	90	90	NUM
ijpds-3583	45	142	112.5	112.5	NUM
ijpds-3583	45	143	4214430	4214430	NUM
ijpds-3583	45	144	100	100	NUM
ijpds-3583	45	145	125	125	NUM
ijpds-3583	45	146	4721514	4721514	NUM
ijpds-3583	45	147	110	110	NUM
ijpds-3583	45	148	137.5	137.5	NUM
ijpds-3583	45	149	5199512	5199512	NUM
ijpds-3583	45	150	120	120	NUM
ijpds-3583	45	151	150	150	NUM
ijpds-3583	45	152	5626385	5626385	NUM
ijpds-3583	45	153	table	table	NOUN
ijpds-3583	45	154	4linearity	4linearity	NUM
ijpds-3583	45	155	values	value	NOUN
ijpds-3583	45	156	of	of	ADP
ijpds-3583	45	157	benidipine	benidipine	NOUN
ijpds-3583	45	158	hydrochloride	hydrochloride	NOUN
ijpds-3583	45	159	and	and	CCONJ
ijpds-3583	45	160	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	45	161	parameter	parameter	NOUN
ijpds-3583	45	162	benidipine	benidipine	PROPN
ijpds-3583	45	163	hydrochloride	hydrochloride	NOUN
ijpds-3583	45	164	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	45	165	range	range	NOUN
ijpds-3583	45	166	32	32	NUM
ijpds-3583	45	167	-	-	SYM
ijpds-3583	45	168	48	48	NUM
ijpds-3583	45	169	µg	µg	NOUN
ijpds-3583	45	170	/	/	SYM
ijpds-3583	45	171	ml	ml	NOUN
ijpds-3583	45	172	100	100	NUM
ijpds-3583	45	173	-	-	PUNCT
ijpds-3583	45	174	150µg	150µg	NOUN
ijpds-3583	45	175	/	/	SYM
ijpds-3583	45	176	ml	ml	NOUN
ijpds-3583	45	177	slope	slope	NOUN
ijpds-3583	45	178	50184	50184	NUM
ijpds-3583	45	179	37102	37102	NUM
ijpds-3583	45	180	intercept	intercept	VERB
ijpds-3583	45	181	30070	30070	NUM
ijpds-3583	45	182	74642	74642	NUM
ijpds-3583	45	183	correlation	correlation	NOUN
ijpds-3583	45	184	coefficient	coefficient	NOUN
ijpds-3583	45	185	0.999	0.999	NUM
ijpds-3583	45	186	0.999	0.999	NUM
ijpds-3583	45	187	method	method	NOUN
ijpds-3583	45	188	validation	validation	NOUN
ijpds-3583	45	189	1	1	NUM
ijpds-3583	46	1	.	.	PUNCT
ijpds-3583	46	2	linearity	linearity	NOUN
ijpds-3583	46	3	:	:	PUNCT
ijpds-3583	46	4	to	to	PART
ijpds-3583	46	5	get	get	AUX
ijpds-3583	46	6	desired	desire	VERB
ijpds-3583	46	7	analyte	analyte	NOUN
ijpds-3583	46	8	concentrations	concentration	NOUN
ijpds-3583	46	9	the	the	DET
ijpds-3583	46	10	standard	standard	ADJ
ijpds-3583	46	11	solution	solution	NOUN
ijpds-3583	46	12	was	be	AUX
ijpds-3583	46	13	created	create	VERB
ijpds-3583	46	14	by	by	ADP
ijpds-3583	46	15	adding	add	VERB
ijpds-3583	46	16	5	5	NUM
ijpds-3583	46	17	mg	mg	NOUN
ijpds-3583	46	18	of	of	ADP
ijpds-3583	46	19	benidipine	benidipine	NOUN
ijpds-3583	46	20	hydrochloride	hydrochloride	NOUN
ijpds-3583	46	21	and	and	CCONJ
ijpds-3583	46	22	12.5	12.5	NUM
ijpds-3583	46	23	mg	mg	NOUN
ijpds-3583	46	24	of	of	ADP
ijpds-3583	46	25	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	46	26	in	in	ADP
ijpds-3583	46	27	10	10	NUM
ijpds-3583	46	28	ml	ml	NOUN
ijpds-3583	46	29	of	of	ADP
ijpds-3583	46	30	volumetric	volumetric	NOUN
ijpds-3583	46	31	flask	flask	NOUN
ijpds-3583	46	32	and	and	CCONJ
ijpds-3583	46	33	make	make	VERB
ijpds-3583	46	34	up	up	ADP
ijpds-3583	46	35	volume	volume	NOUN
ijpds-3583	46	36	up	up	ADP
ijpds-3583	46	37	to	to	PART
ijpds-3583	46	38	10	10	NUM
ijpds-3583	46	39	ml	ml	NOUN
ijpds-3583	46	40	using	use	VERB
ijpds-3583	46	41	diluent	diluent	NOUN
ijpds-3583	46	42	then	then	ADV
ijpds-3583	46	43	further	further	ADJ
ijpds-3583	46	44	dilution	dilution	NOUN
ijpds-3583	46	45	was	be	AUX
ijpds-3583	46	46	made	make	VERB
ijpds-3583	46	47	to	to	PART
ijpds-3583	46	48	get	get	VERB
ijpds-3583	46	49	32	32	NUM
ijpds-3583	46	50	-	-	PUNCT
ijpds-3583	46	51	48µg	48µg	NOUN
ijpds-3583	46	52	/	/	SYM
ijpds-3583	46	53	ml	ml	X
ijpds-3583	46	54	of	of	ADP
ijpds-3583	46	55	benidipine	benidipine	NOUN
ijpds-3583	46	56	hydrochloride	hydrochloride	NOUN
ijpds-3583	46	57	and	and	CCONJ
ijpds-3583	46	58	100	100	NUM
ijpds-3583	46	59	-	-	PUNCT
ijpds-3583	46	60	150µg	150µg	NOUN
ijpds-3583	46	61	/	/	SYM
ijpds-3583	46	62	ml	ml	X
ijpds-3583	46	63	respectively	respectively	ADV
ijpds-3583	46	64	.	.	PUNCT
ijpds-3583	47	1	the	the	DET
ijpds-3583	47	2	correlation	correlation	NOUN
ijpds-3583	47	3	coefficient	coefficient	NOUN
ijpds-3583	47	4	for	for	ADP
ijpds-3583	47	5	calibration	calibration	NOUN
ijpds-3583	47	6	curve	curve	NOUN
ijpds-3583	47	7	benidipine	benidipine	NOUN
ijpds-3583	47	8	hydrochloride	hydrochloride	NOUN
ijpds-3583	47	9	and	and	CCONJ
ijpds-3583	47	10	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	47	11	was	be	AUX
ijpds-3583	47	12	found	find	VERB
ijpds-3583	47	13	to	to	PART
ijpds-3583	47	14	be	be	AUX
ijpds-3583	47	15	0.999	0.999	NUM
ijpds-3583	47	16	and	and	CCONJ
ijpds-3583	47	17	0.999	0.999	NUM
ijpds-3583	47	18	respectively	respectively	ADV
ijpds-3583	47	19	(	(	PUNCT
ijpds-3583	47	20	table	table	NOUN
ijpds-3583	47	21	4	4	NUM
ijpds-3583	47	22	)	)	PUNCT
ijpds-3583	47	23	.	.	PUNCT
ijpds-3583	48	1	fig	fig	NOUN
ijpds-3583	48	2	.	.	PUNCT
ijpds-3583	49	1	3	3	NUM
ijpds-3583	49	2	chromatogram	chromatogram	NOUN
ijpds-3583	49	3	of	of	ADP
ijpds-3583	49	4	standard	standard	ADJ
ijpds-3583	49	5	mixture	mixture	NOUN
ijpds-3583	49	6	of	of	ADP
ijpds-3583	49	7	benidipine	benidipine	NOUN
ijpds-3583	49	8	hydrochloride	hydrochloride	NOUN
ijpds-3583	49	9	&	&	CCONJ
ijpds-3583	49	10	chlorthalidone	chlorthalidone	PROPN
ijpds-3583	49	11	2	2	NUM
ijpds-3583	49	12	.	.	PUNCT
ijpds-3583	49	13	precision	precision	NOUN
ijpds-3583	49	14	:	:	PUNCT
ijpds-3583	49	15	precision	precision	NOUN
ijpds-3583	49	16	of	of	ADP
ijpds-3583	49	17	an	an	DET
ijpds-3583	49	18	analytical	analytical	ADJ
ijpds-3583	49	19	procedure	procedure	NOUN
ijpds-3583	49	20	express	express	VERB
ijpds-3583	49	21	the	the	DET
ijpds-3583	49	22	closeness	closeness	NOUN
ijpds-3583	49	23	of	of	ADP
ijpds-3583	49	24	agreement	agreement	NOUN
ijpds-3583	49	25	between	between	ADP
ijpds-3583	49	26	a	a	DET
ijpds-3583	49	27	series	series	NOUN
ijpds-3583	49	28	of	of	ADP
ijpds-3583	49	29	measurement	measurement	NOUN
ijpds-3583	49	30	obtained	obtain	VERB
ijpds-3583	49	31	from	from	ADP
ijpds-3583	49	32	multiple	multiple	ADJ
ijpds-3583	49	33	sampling	sampling	NOUN
ijpds-3583	49	34	of	of	ADP
ijpds-3583	49	35	same	same	ADJ
ijpds-3583	49	36	homologous	homologous	ADJ
ijpds-3583	49	37	sample	sample	NOUN
ijpds-3583	49	38	under	under	ADP
ijpds-3583	49	39	précised	précise	VERB
ijpds-3583	49	40	condition	condition	NOUN
ijpds-3583	49	41	.	.	PUNCT
ijpds-3583	50	1	intraday	intraday	NOUN
ijpds-3583	50	2	precision	precision	NOUN
ijpds-3583	50	3	for	for	ADP
ijpds-3583	50	4	benidipine	benidipine	NOUN
ijpds-3583	50	5	hydrochloride	hydrochloride	NOUN
ijpds-3583	50	6	and	and	CCONJ
ijpds-3583	50	7	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	50	8	are	be	AUX
ijpds-3583	50	9	shown	show	VERB
ijpds-3583	50	10	in	in	ADP
ijpds-3583	50	11	table	table	NOUN
ijpds-3583	50	12	no	no	INTJ
ijpds-3583	50	13	.	.	PUNCT
ijpds-3583	51	1	(	(	PUNCT
ijpds-3583	51	2	5&6	5&6	NUM
ijpds-3583	51	3	)	)	PUNCT
ijpds-3583	51	4	.	.	PUNCT
ijpds-3583	52	1	the	the	DET
ijpds-3583	52	2	%	%	NOUN
ijpds-3583	52	3	rsd	rsd	NOUN
ijpds-3583	52	4	for	for	ADP
ijpds-3583	52	5	benidipine	benidipine	NOUN
ijpds-3583	52	6	hydrochloride	hydrochloride	NOUN
ijpds-3583	52	7	and	and	CCONJ
ijpds-3583	52	8	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	52	9	was	be	AUX
ijpds-3583	52	10	found	find	VERB
ijpds-3583	52	11	to	to	PART
ijpds-3583	52	12	be	be	AUX
ijpds-3583	52	13	0.161and	0.161and	NOUN
ijpds-3583	52	14	0.390	0.390	NUM
ijpds-3583	52	15	,	,	PUNCT
ijpds-3583	52	16	respectively	respectively	ADV
ijpds-3583	52	17	.	.	PUNCT
ijpds-3583	53	1	interday	interday	PROPN
ijpds-3583	53	2	precision	precision	NOUN
ijpds-3583	53	3	for	for	ADP
ijpds-3583	53	4	benidipine	benidipine	NOUN
ijpds-3583	53	5	hydrochloride	hydrochloride	NOUN
ijpds-3583	53	6	and	and	CCONJ
ijpds-3583	53	7	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	53	8	are	be	AUX
ijpds-3583	53	9	shown	show	VERB
ijpds-3583	53	10	in	in	ADP
ijpds-3583	53	11	table	table	NOUN
ijpds-3583	53	12	no	no	INTJ
ijpds-3583	53	13	.	.	PUNCT
ijpds-3583	54	1	(	(	PUNCT
ijpds-3583	54	2	7&8	7&8	NUM
ijpds-3583	54	3	)	)	PUNCT
ijpds-3583	54	4	.	.	PUNCT
ijpds-3583	55	1	the	the	DET
ijpds-3583	55	2	%	%	NOUN
ijpds-3583	55	3	rsd	rsd	NOUN
ijpds-3583	55	4	or	or	CCONJ
ijpds-3583	55	5	benidipine	benidipine	NOUN
ijpds-3583	55	6	hydrochloride	hydrochloride	NOUN
ijpds-3583	55	7	and	and	CCONJ
ijpds-3583	55	8	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	55	9	was	be	AUX
ijpds-3583	55	10	found	find	VERB
ijpds-3583	55	11	to	to	PART
ijpds-3583	55	12	be	be	AUX
ijpds-3583	55	13	0.27and	0.27and	NUM
ijpds-3583	55	14	0.41	0.41	NUM
ijpds-3583	55	15	,	,	PUNCT
ijpds-3583	55	16	respectively	respectively	ADV
ijpds-3583	55	17	.	.	PUNCT
ijpds-3583	56	1	fig	fig	NOUN
ijpds-3583	56	2	.	.	PUNCT
ijpds-3583	57	1	4	4	NUM
ijpds-3583	57	2	linearity	linearity	NOUN
ijpds-3583	57	3	graph	graph	NOUN
ijpds-3583	57	4	of	of	ADP
ijpds-3583	57	5	benidipine	benidipine	NOUN
ijpds-3583	57	6	hydrochloride	hydrochloride	NOUN
ijpds-3583	57	7	3	3	NUM
ijpds-3583	57	8	.	.	PUNCT
ijpds-3583	58	1	lod	lod	PROPN
ijpds-3583	58	2	&	&	CCONJ
ijpds-3583	58	3	loq	loq	PROPN
ijpds-3583	58	4	:	:	PUNCT
ijpds-3583	58	5	limit	limit	NOUN
ijpds-3583	58	6	of	of	ADP
ijpds-3583	58	7	detection	detection	NOUN
ijpds-3583	58	8	(	(	PUNCT
ijpds-3583	58	9	lod	lod	PROPN
ijpds-3583	58	10	)	)	PUNCT
ijpds-3583	58	11	means	mean	VERB
ijpds-3583	58	12	the	the	DET
ijpds-3583	58	13	detection	detection	NOUN
ijpds-3583	58	14	of	of	ADP
ijpds-3583	58	15	an	an	DET
ijpds-3583	58	16	individual	individual	ADJ
ijpds-3583	58	17	analytical	analytical	ADJ
ijpds-3583	58	18	procedure	procedure	NOUN
ijpds-3583	58	19	express	express	VERB
ijpds-3583	58	20	the	the	DET
ijpds-3583	58	21	closeness	closeness	NOUN
ijpds-3583	58	22	of	of	ADP
ijpds-3583	58	23	agreement	agreement	NOUN
ijpds-3583	58	24	between	between	ADP
ijpds-3583	58	25	a	a	DET
ijpds-3583	58	26	series	series	NOUN
ijpds-3583	58	27	of	of	ADP
ijpds-3583	58	28	measurement	measurement	NOUN
ijpds-3583	58	29	obtained	obtain	VERB
ijpds-3583	58	30	from	from	ADP
ijpds-3583	58	31	multiple	multiple	ADJ
ijpds-3583	58	32	sampling	sampling	NOUN
ijpds-3583	58	33	of	of	ADP
ijpds-3583	58	34	same	same	ADJ
ijpds-3583	58	35	homologous	homologous	ADJ
ijpds-3583	58	36	sample	sample	NOUN
ijpds-3583	58	37	under	under	ADP
ijpds-3583	58	38	précised	précise	VERB
ijpds-3583	58	39	condition	condition	NOUN
ijpds-3583	58	40	and	and	CCONJ
ijpds-3583	58	41	limit	limit	NOUN
ijpds-3583	58	42	of	of	ADP
ijpds-3583	58	43	quantitation	quantitation	NOUN
ijpds-3583	58	44	(	(	PUNCT
ijpds-3583	58	45	loq	loq	PROPN
ijpds-3583	58	46	)	)	PUNCT
ijpds-3583	58	47	means	mean	VERB
ijpds-3583	58	48	the	the	DET
ijpds-3583	58	49	quantitation	quantitation	NOUN
ijpds-3583	58	50	of	of	ADP
ijpds-3583	58	51	an	an	DET
ijpds-3583	58	52	analytical	analytical	ADJ
ijpds-3583	58	53	procedure	procedure	NOUN
ijpds-3583	58	54	is	be	AUX
ijpds-3583	58	55	the	the	DET
ijpds-3583	58	56	lowest	low	ADJ
ijpds-3583	58	57	amount	amount	NOUN
ijpds-3583	58	58	of	of	ADP
ijpds-3583	58	59	an	an	DET
ijpds-3583	58	60	analyte	analyte	NOUN
ijpds-3583	58	61	in	in	ADP
ijpds-3583	58	62	a	a	DET
ijpds-3583	58	63	sample	sample	NOUN
ijpds-3583	58	64	which	which	PRON
ijpds-3583	58	65	can	can	AUX
ijpds-3583	58	66	be	be	AUX
ijpds-3583	58	67	quantitatively	quantitatively	ADV
ijpds-3583	58	68	determine	determine	VERB
ijpds-3583	58	69	with	with	ADP
ijpds-3583	58	70	suitable	suitable	ADJ
ijpds-3583	58	71	precision	precision	NOUN
ijpds-3583	58	72	and	and	CCONJ
ijpds-3583	58	73	accuracy	accuracy	NOUN
ijpds-3583	58	74	.	.	PUNCT
ijpds-3583	59	1	it	it	PRON
ijpds-3583	59	2	can	can	AUX
ijpds-3583	59	3	be	be	AUX
ijpds-3583	59	4	calculated	calculate	VERB
ijpds-3583	59	5	using	use	VERB
ijpds-3583	59	6	formula	formula	NOUN
ijpds-3583	59	7	3.3	3.3	NUM
ijpds-3583	59	8	σ	σ	NOUN
ijpds-3583	59	9	/	/	SYM
ijpds-3583	59	10	s	s	PROPN
ijpds-3583	59	11	and	and	CCONJ
ijpds-3583	59	12	10	10	NUM
ijpds-3583	59	13	σ	σ	PROPN
ijpds-3583	59	14	/	/	SYM
ijpds-3583	59	15	s	s	PROPN
ijpds-3583	59	16	,	,	PUNCT
ijpds-3583	59	17	respectively	respectively	ADV
ijpds-3583	59	18	.	.	PUNCT
ijpds-3583	60	1	where	where	SCONJ
ijpds-3583	60	2	σ	σ	PROPN
ijpds-3583	60	3	is	be	AUX
ijpds-3583	60	4	sd	sd	ADP
ijpds-3583	60	5	of	of	ADP
ijpds-3583	60	6	yintercepts	yintercept	NOUN
ijpds-3583	60	7	of	of	ADP
ijpds-3583	60	8	regression	regression	NOUN
ijpds-3583	60	9	line	line	NOUN
ijpds-3583	60	10	and	and	CCONJ
ijpds-3583	60	11	s	s	NOUN
ijpds-3583	60	12	is	be	AUX
ijpds-3583	60	13	slope	slope	NOUN
ijpds-3583	60	14	of	of	ADP
ijpds-3583	60	15	calibration	calibration	NOUN
ijpds-3583	60	16	curve	curve	NOUN
ijpds-3583	60	17	(	(	PUNCT
ijpds-3583	60	18	table	table	NOUN
ijpds-3583	60	19	13	13	NUM
ijpds-3583	60	20	)	)	PUNCT
ijpds-3583	60	21	.	.	PUNCT
ijpds-3583	61	1	4	4	X
ijpds-3583	61	2	.	.	X
ijpds-3583	61	3	robustness	robustness	NOUN
ijpds-3583	61	4	:	:	PUNCT
ijpds-3583	61	5	this	this	PRON
ijpds-3583	61	6	was	be	AUX
ijpds-3583	61	7	done	do	VERB
ijpds-3583	61	8	by	by	ADP
ijpds-3583	61	9	minute	minute	ADJ
ijpds-3583	61	10	changes	change	NOUN
ijpds-3583	61	11	in	in	ADP
ijpds-3583	61	12	the	the	DET
ijpds-3583	61	13	chromatographic	chromatographic	ADJ
ijpds-3583	61	14	condition	condition	NOUN
ijpds-3583	61	15	and	and	CCONJ
ijpds-3583	61	16	found	find	VERB
ijpds-3583	61	17	to	to	PART
ijpds-3583	61	18	be	be	AUX
ijpds-3583	61	19	unchanged	unchanged	ADJ
ijpds-3583	61	20	by	by	ADP
ijpds-3583	61	21	minute	minute	ADJ
ijpds-3583	61	22	changes	change	NOUN
ijpds-3583	61	23	like	like	ADP
ijpds-3583	61	24	±2	±2	NOUN
ijpds-3583	61	25	%	%	NOUN
ijpds-3583	61	26	changes	change	NOUN
ijpds-3583	61	27	in	in	ADP
ijpds-3583	61	28	volume	volume	NOUN
ijpds-3583	61	29	of	of	ADP
ijpds-3583	61	30	organic	organic	ADJ
ijpds-3583	61	31	solution	solution	NOUN
ijpds-3583	61	32	of	of	ADP
ijpds-3583	61	33	mobile	mobile	ADJ
ijpds-3583	61	34	phase	phase	NOUN
ijpds-3583	61	35	.	.	PUNCT
ijpds-3583	62	1	fig	fig	NOUN
ijpds-3583	62	2	.	.	PUNCT
ijpds-3583	63	1	5	5	NUM
ijpds-3583	63	2	linearity	linearity	NOUN
ijpds-3583	63	3	graph	graph	NOUN
ijpds-3583	63	4	of	of	ADP
ijpds-3583	63	5	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	63	6	5	5	NUM
ijpds-3583	63	7	.	.	PUNCT
ijpds-3583	63	8	accuracy	accuracy	NOUN
ijpds-3583	63	9	:	:	PUNCT
ijpds-3583	63	10	accuracy	accuracy	NOUN
ijpds-3583	63	11	is	be	AUX
ijpds-3583	63	12	the	the	DET
ijpds-3583	63	13	closeness	closeness	NOUN
ijpds-3583	63	14	of	of	ADP
ijpds-3583	63	15	agreement	agreement	NOUN
ijpds-3583	63	16	between	between	ADP
ijpds-3583	63	17	the	the	DET
ijpds-3583	63	18	values	value	NOUN
ijpds-3583	63	19	found	find	VERB
ijpds-3583	63	20	.	.	PUNCT
ijpds-3583	64	1	the	the	DET
ijpds-3583	64	2	value	value	NOUN
ijpds-3583	64	3	accepted	accept	VERB
ijpds-3583	64	4	as	as	ADP
ijpds-3583	64	5	the	the	DET
ijpds-3583	64	6	conventional	conventional	ADJ
ijpds-3583	64	7	true	true	ADJ
ijpds-3583	64	8	value	value	NOUN
ijpds-3583	64	9	or	or	CCONJ
ijpds-3583	64	10	the	the	DET
ijpds-3583	64	11	accepted	accept	VERB
ijpds-3583	64	12	reference	reference	NOUN
ijpds-3583	64	13	value	value	NOUN
ijpds-3583	64	14	.	.	PUNCT
ijpds-3583	65	1	the	the	DET
ijpds-3583	65	2	accuracy	accuracy	NOUN
ijpds-3583	65	3	of	of	ADP
ijpds-3583	65	4	the	the	DET
ijpds-3583	65	5	y	y	PROPN
ijpds-3583	65	6	=	=	PROPN
ijpds-3583	65	7	37102x	37102x	NOUN
ijpds-3583	65	8	+	+	CCONJ
ijpds-3583	65	9	74642	74642	NUM
ijpds-3583	65	10	r²	r²	VERB
ijpds-3583	65	11	=	=	NOUN
ijpds-3583	65	12	0.999	0.999	NUM
ijpds-3583	65	13	3400000	3400000	NUM
ijpds-3583	65	14	3900000	3900000	NUM
ijpds-3583	65	15	4400000	4400000	NUM
ijpds-3583	65	16	4900000	4900000	NUM
ijpds-3583	65	17	5400000	5400000	NUM
ijpds-3583	65	18	5900000	5900000	NUM
ijpds-3583	65	19	80	80	NUM
ijpds-3583	65	20	130	130	NUM
ijpds-3583	65	21	180	180	NUM
ijpds-3583	65	22	concentration	concentration	NOUN
ijpds-3583	65	23	(	(	PUNCT
ijpds-3583	65	24	µ	µ	NOUN
ijpds-3583	65	25	g	g	NOUN
ijpds-3583	65	26	/	/	SYM
ijpds-3583	65	27	ml	ml	NOUN
ijpds-3583	65	28	)	)	PUNCT
ijpds-3583	65	29	linearity	linearity	NOUN
ijpds-3583	65	30	of	of	ADP
ijpds-3583	65	31	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	65	32	y	y	PROPN
ijpds-3583	65	33	=	=	SYM
ijpds-3583	65	34	50184x	50184x	NUM
ijpds-3583	65	35	30070	30070	NUM
ijpds-3583	65	36	r²	r²	NOUN
ijpds-3583	65	37	=	=	SYM
ijpds-3583	65	38	0.9993	0.9993	NUM
ijpds-3583	65	39	1200000	1200000	NUM
ijpds-3583	65	40	1400000	1400000	NUM
ijpds-3583	65	41	1600000	1600000	NUM
ijpds-3583	65	42	1800000	1800000	NUM
ijpds-3583	65	43	2000000	2000000	NUM
ijpds-3583	65	44	2200000	2200000	NUM
ijpds-3583	65	45	2400000	2400000	NUM
ijpds-3583	65	46	2600000	2600000	NUM
ijpds-3583	65	47	28	28	NUM
ijpds-3583	65	48	38	38	NUM
ijpds-3583	65	49	48	48	NUM
ijpds-3583	65	50	58	58	NUM
ijpds-3583	65	51	concentration	concentration	NOUN
ijpds-3583	65	52	(	(	PUNCT
ijpds-3583	65	53	ug	ug	ADP
ijpds-3583	65	54	/	/	SYM
ijpds-3583	65	55	ml	ml	NOUN
ijpds-3583	65	56	)	)	PUNCT
ijpds-3583	65	57	linearity	linearity	NOUN
ijpds-3583	65	58	of	of	ADP
ijpds-3583	65	59	benedipine	benedipine	NOUN
ijpds-3583	65	60	shaikhmulani	shaikhmulani	PROPN
ijpds-3583	65	61	et	et	PROPN
ijpds-3583	65	62	al	al	PROPN
ijpds-3583	65	63	rp	rp	PROPN
ijpds-3583	65	64	-	-	PUNCT
ijpds-3583	65	65	hplc	hplc	NOUN
ijpds-3583	65	66	method	method	NOUN
ijpds-3583	65	67	development	development	NOUN
ijpds-3583	65	68	and	and	CCONJ
ijpds-3583	65	69	validation	validation	NOUN
ijpds-3583	65	70	of	of	ADP
ijpds-3583	65	71	ben.hcl	ben.hcl	PROPN
ijpds-3583	65	72	&	&	CCONJ
ijpds-3583	65	73	ctd	ctd	PROPN
ijpds-3583	65	74	vol	vol	NOUN
ijpds-3583	65	75	1	1	NUM
ijpds-3583	65	76	|	|	NOUN
ijpds-3583	65	77	issue	issue	NOUN
ijpds-3583	65	78	3	3	NUM
ijpds-3583	65	79	|	|	ADV
ijpds-3583	65	80	oct	oct	PROPN
ijpds-3583	65	81	–	–	PUNCT
ijpds-3583	65	82	dec	dec	PROPN
ijpds-3583	65	83	2022	2022	NUM
ijpds-3583	65	84	indian	indian	PROPN
ijpds-3583	65	85	j	j	PROPN
ijpds-3583	65	86	pharm	pharm	PROPN
ijpds-3583	65	87	drug	drug	PROPN
ijpds-3583	65	88	studies	study	NOUN
ijpds-3583	65	89	|	|	ADV
ijpds-3583	65	90	105	105	NUM
ijpds-3583	65	91	method	method	NOUN
ijpds-3583	65	92	was	be	AUX
ijpds-3583	65	93	confirmed	confirm	VERB
ijpds-3583	65	94	by	by	ADP
ijpds-3583	65	95	recovery	recovery	NOUN
ijpds-3583	65	96	study	study	NOUN
ijpds-3583	65	97	from	from	ADP
ijpds-3583	65	98	the	the	DET
ijpds-3583	65	99	marketed	market	VERB
ijpds-3583	65	100	formulation	formulation	NOUN
ijpds-3583	65	101	at	at	ADP
ijpds-3583	65	102	three	three	NUM
ijpds-3583	65	103	level	level	NOUN
ijpds-3583	65	104	of	of	ADP
ijpds-3583	65	105	standard	standard	ADJ
ijpds-3583	65	106	addition	addition	NOUN
ijpds-3583	65	107	(	(	PUNCT
ijpds-3583	65	108	table	table	NOUN
ijpds-3583	65	109	9	9	NUM
ijpds-3583	65	110	&	&	CCONJ
ijpds-3583	65	111	10	10	NUM
ijpds-3583	65	112	)	)	PUNCT
ijpds-3583	65	113	.	.	PUNCT
ijpds-3583	66	1	6	6	X
ijpds-3583	66	2	.	.	X
ijpds-3583	66	3	system	system	NOUN
ijpds-3583	66	4	suitability	suitability	NOUN
ijpds-3583	66	5	parameters	parameter	NOUN
ijpds-3583	66	6	:	:	PUNCT
ijpds-3583	66	7	7	7	X
ijpds-3583	66	8	.	.	X
ijpds-3583	66	9	specificity	specificity	NOUN
ijpds-3583	66	10	:	:	PUNCT
ijpds-3583	66	11	specificity	specificity	NOUN
ijpds-3583	66	12	is	be	AUX
ijpds-3583	66	13	ability	ability	NOUN
ijpds-3583	66	14	to	to	PART
ijpds-3583	66	15	assess	assess	VERB
ijpds-3583	66	16	the	the	DET
ijpds-3583	66	17	analyte	analyte	NOUN
ijpds-3583	66	18	for	for	ADP
ijpds-3583	66	19	the	the	DET
ijpds-3583	66	20	presence	presence	NOUN
ijpds-3583	66	21	of	of	ADP
ijpds-3583	66	22	various	various	ADJ
ijpds-3583	66	23	components	component	NOUN
ijpds-3583	66	24	that	that	PRON
ijpds-3583	66	25	may	may	AUX
ijpds-3583	66	26	be	be	AUX
ijpds-3583	66	27	present	present	ADJ
ijpds-3583	66	28	.	.	PUNCT
ijpds-3583	67	1	specificity	specificity	NOUN
ijpds-3583	67	2	of	of	ADP
ijpds-3583	67	3	the	the	DET
ijpds-3583	67	4	rp_hplc	rp_hplc	NOUN
ijpds-3583	67	5	method	method	NOUN
ijpds-3583	67	6	was	be	AUX
ijpds-3583	67	7	determined	determine	VERB
ijpds-3583	67	8	by	by	ADP
ijpds-3583	67	9	entire	entire	ADJ
ijpds-3583	67	10	separation	separation	NOUN
ijpds-3583	67	11	of	of	ADP
ijpds-3583	67	12	benidipine	benidipine	NOUN
ijpds-3583	67	13	hydrochloride	hydrochloride	NOUN
ijpds-3583	67	14	and	and	CCONJ
ijpds-3583	67	15	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	67	16	with	with	ADP
ijpds-3583	67	17	parameter	parameter	NOUN
ijpds-3583	67	18	like	like	ADP
ijpds-3583	67	19	retention	retention	NOUN
ijpds-3583	67	20	time	time	NOUN
ijpds-3583	67	21	(	(	PUNCT
ijpds-3583	67	22	rt	rt	NOUN
ijpds-3583	67	23	)	)	PUNCT
ijpds-3583	67	24	,	,	PUNCT
ijpds-3583	67	25	resolution	resolution	NOUN
ijpds-3583	67	26	(	(	PUNCT
ijpds-3583	67	27	rs	rs	NOUN
ijpds-3583	67	28	)	)	PUNCT
ijpds-3583	67	29	and	and	CCONJ
ijpds-3583	67	30	tailing	tail	VERB
ijpds-3583	67	31	factor	factor	NOUN
ijpds-3583	67	32	(	(	PUNCT
ijpds-3583	67	33	t	t	PROPN
ijpds-3583	67	34	)	)	PUNCT
ijpds-3583	67	35	.	.	PUNCT
ijpds-3583	68	1	the	the	DET
ijpds-3583	68	2	peak	peak	NOUN
ijpds-3583	68	3	obtained	obtain	VERB
ijpds-3583	68	4	for	for	ADP
ijpds-3583	68	5	benidipine	benidipine	NOUN
ijpds-3583	68	6	hydrochloride	hydrochloride	NOUN
ijpds-3583	68	7	and	and	CCONJ
ijpds-3583	68	8	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	68	9	were	be	AUX
ijpds-3583	68	10	sharp	sharp	ADJ
ijpds-3583	68	11	and	and	CCONJ
ijpds-3583	68	12	have	have	VERB
ijpds-3583	68	13	a	a	DET
ijpds-3583	68	14	clear	clear	ADJ
ijpds-3583	68	15	baseline	baseline	NOUN
ijpds-3583	68	16	separation	separation	NOUN
ijpds-3583	68	17	.	.	PUNCT
ijpds-3583	69	1	the	the	DET
ijpds-3583	69	2	results	result	NOUN
ijpds-3583	69	3	are	be	AUX
ijpds-3583	69	4	shown	show	VERB
ijpds-3583	69	5	in	in	ADP
ijpds-3583	69	6	table	table	NOUN
ijpds-3583	69	7	12	12	NUM
ijpds-3583	69	8	.	.	PUNCT
ijpds-3583	69	9	table	table	NOUN
ijpds-3583	69	10	5	5	NUM
ijpds-3583	69	11	intraday	intraday	NOUN
ijpds-3583	69	12	precision	precision	NOUN
ijpds-3583	69	13	study	study	NOUN
ijpds-3583	69	14	of	of	ADP
ijpds-3583	69	15	benidipine	benidipine	NOUN
ijpds-3583	69	16	hydrochloride	hydrochloride	NOUN
ijpds-3583	69	17	concentration	concentration	NOUN
ijpds-3583	69	18	in	in	ADP
ijpds-3583	69	19	µg	µg	ADV
ijpds-3583	69	20	/	/	SYM
ijpds-3583	69	21	ml	ml	NOUN
ijpds-3583	69	22	area	area	NOUN
ijpds-3583	69	23	%	%	NOUN
ijpds-3583	69	24	recovery	recovery	NOUN
ijpds-3583	70	1	mean	mean	NOUN
ijpds-3583	70	2	%	%	NOUN
ijpds-3583	70	3	recovery	recovery	NOUN
ijpds-3583	70	4	±	±	NOUN
ijpds-3583	70	5	sd	sd	ADP
ijpds-3583	70	6	mean	mean	ADJ
ijpds-3583	70	7	%	%	NOUN
ijpds-3583	70	8	recovery	recovery	NOUN
ijpds-3583	70	9	±rsd	±rsd	NOUN
ijpds-3583	70	10	1612694	1612694	NUM
ijpds-3583	70	11	98.55	98.55	NUM
ijpds-3583	70	12	32	32	NUM
ijpds-3583	70	13	µg	µg	NOUN
ijpds-3583	70	14	/	/	SYM
ijpds-3583	70	15	ml	ml	NOUN
ijpds-3583	70	16	1613005	1613005	NUM
ijpds-3583	70	17	98.57	98.57	NUM
ijpds-3583	71	1	98.59±0.064	98.59±0.064	NUM
ijpds-3583	71	2	1614658	1614658	NUM
ijpds-3583	71	3	98.67	98.67	NUM
ijpds-3583	71	4	1825799	1825799	NUM
ijpds-3583	71	5	99.39	99.39	NUM
ijpds-3583	71	6	99.21±0.161	99.21±0.161	NUM
ijpds-3583	71	7	36	36	NUM
ijpds-3583	71	8	µg	µg	NOUN
ijpds-3583	71	9	/	/	SYM
ijpds-3583	71	10	ml	ml	ADP
ijpds-3583	71	11	1836154	1836154	NUM
ijpds-3583	71	12	99.97	99.97	NUM
ijpds-3583	71	13	99.79±0.34	99.79±0.34	NUM
ijpds-3583	71	14	1837001	1837001	NUM
ijpds-3583	71	15	100.01	100.01	NUM
ijpds-3583	71	16	2023149	2023149	NUM
ijpds-3583	71	17	99.28	99.28	NUM
ijpds-3583	71	18	40	40	NUM
ijpds-3583	71	19	µg	µg	NOUN
ijpds-3583	71	20	/	/	SYM
ijpds-3583	71	21	ml	ml	PROPN
ijpds-3583	71	22	2024153	2024153	NUM
ijpds-3583	71	23	99.33	99.33	NUM
ijpds-3583	71	24	99.25±0.08	99.25±0.08	NUM
ijpds-3583	71	25	2020746	2020746	NUM
ijpds-3583	71	26	99.16	99.16	NUM
ijpds-3583	71	27	table	table	NOUN
ijpds-3583	71	28	6	6	NUM
ijpds-3583	71	29	intraday	intraday	NOUN
ijpds-3583	71	30	precision	precision	NOUN
ijpds-3583	71	31	study	study	NOUN
ijpds-3583	71	32	of	of	ADP
ijpds-3583	71	33	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	71	34	concentration	concentration	NOUN
ijpds-3583	71	35	in	in	ADP
ijpds-3583	71	36	µg	µg	ADV
ijpds-3583	71	37	/	/	SYM
ijpds-3583	71	38	ml	ml	NOUN
ijpds-3583	71	39	area	area	NOUN
ijpds-3583	71	40	%	%	NOUN
ijpds-3583	71	41	recovery	recovery	NOUN
ijpds-3583	71	42	mean	mean	NOUN
ijpds-3583	71	43	%	%	NOUN
ijpds-3583	71	44	recovery	recovery	NOUN
ijpds-3583	71	45	±	±	NOUN
ijpds-3583	71	46	sd	sd	ADP
ijpds-3583	71	47	mean	mean	ADJ
ijpds-3583	72	1	%	%	NOUN
ijpds-3583	73	1	recovery	recovery	NOUN
ijpds-3583	73	2	±rsd	±rsd	NOUN
ijpds-3583	73	3	3794817	3794817	NUM
ijpds-3583	73	4	100.26	100.26	NUM
ijpds-3583	73	5	99.53±0.66	99.53±0.66	NUM
ijpds-3583	73	6	100	100	NUM
ijpds-3583	73	7	µg	µg	NOUN
ijpds-3583	73	8	/	/	SYM
ijpds-3583	73	9	ml	ml	ADP
ijpds-3583	73	10	3745628	3745628	NUM
ijpds-3583	73	11	98.94	98.94	NUM
ijpds-3583	73	12	3767898	3767898	NUM
ijpds-3583	73	13	99.41	99.41	NUM
ijpds-3583	73	14	4256897	4256897	NUM
ijpds-3583	73	15	100.19	100.19	NUM
ijpds-3583	73	16	99.75±0.49	99.75±0.49	NOUN
ijpds-3583	73	17	122.5	122.5	NUM
ijpds-3583	73	18	µg	µg	NOUN
ijpds-3583	73	19	/	/	SYM
ijpds-3583	73	20	ml	ml	ADP
ijpds-3583	73	21	4215783	4215783	NUM
ijpds-3583	73	22	99.21	99.21	NUM
ijpds-3583	73	23	99.75±0.39	99.75±0.39	NUM
ijpds-3583	73	24	4243162	4243162	NUM
ijpds-3583	73	25	99.86	99.86	NUM
ijpds-3583	73	26	4712539	4712539	NUM
ijpds-3583	73	27	100	100	NUM
ijpds-3583	73	28	99.98±0.02	99.98±0.02	NUM
ijpds-3583	73	29	125	125	NUM
ijpds-3583	73	30	µg	µg	NOUN
ijpds-3583	73	31	/	/	SYM
ijpds-3583	73	32	ml	ml	ADP
ijpds-3583	73	33	4710986	4710986	NUM
ijpds-3583	73	34	99.96	99.96	NUM
ijpds-3583	73	35	4711656	4711656	NUM
ijpds-3583	73	36	99.98	99.98	NUM
ijpds-3583	73	37	table	table	NOUN
ijpds-3583	73	38	7	7	NUM
ijpds-3583	73	39	interday	interday	NOUN
ijpds-3583	73	40	precision	precision	NOUN
ijpds-3583	73	41	study	study	NOUN
ijpds-3583	73	42	of	of	ADP
ijpds-3583	73	43	benidipine	benidipine	NOUN
ijpds-3583	73	44	hydrochloride	hydrochloride	NOUN
ijpds-3583	73	45	concentration	concentration	NOUN
ijpds-3583	73	46	in	in	ADP
ijpds-3583	73	47	µg	µg	ADV
ijpds-3583	73	48	/	/	SYM
ijpds-3583	73	49	ml	ml	NOUN
ijpds-3583	73	50	area	area	NOUN
ijpds-3583	73	51	%	%	NOUN
ijpds-3583	73	52	recovery	recovery	NOUN
ijpds-3583	74	1	mean	mean	NOUN
ijpds-3583	74	2	%	%	NOUN
ijpds-3583	74	3	recovery	recovery	NOUN
ijpds-3583	74	4	±	±	NOUN
ijpds-3583	74	5	sd	sd	ADP
ijpds-3583	74	6	mean	mean	ADJ
ijpds-3583	74	7	%	%	NOUN
ijpds-3583	74	8	recovery	recovery	NOUN
ijpds-3583	74	9	±rsd	±rsd	NOUN
ijpds-3583	74	10	32	32	NUM
ijpds-3583	74	11	µg	µg	NOUN
ijpds-3583	74	12	/	/	SYM
ijpds-3583	74	13	ml	ml	PROPN
ijpds-3583	74	14	1611936	1611936	NUM
ijpds-3583	74	15	98.50	98.50	NUM
ijpds-3583	74	16	98.45±0.04	98.45±0.04	NUM
ijpds-3583	74	17	97.93±0.270	97.93±0.270	NUM
ijpds-3583	74	18	1611127	1611127	NUM
ijpds-3583	74	19	98.45	98.45	NUM
ijpds-3583	74	20	1610456	1610456	NUM
ijpds-3583	74	21	98.41	98.41	NUM
ijpds-3583	74	22	36	36	NUM
ijpds-3583	74	23	µg	µg	NOUN
ijpds-3583	74	24	/	/	SYM
ijpds-3583	74	25	ml	ml	PROPN
ijpds-3583	74	26	1796321	1796321	NUM
ijpds-3583	74	27	97.76	97.76	NUM
ijpds-3583	74	28	97.48±0.44	97.48±0.44	NUM
ijpds-3583	74	29	1795854	1795854	NUM
ijpds-3583	74	30	97.73	97.73	NUM
ijpds-3583	74	31	1789500	1789500	NUM
ijpds-3583	74	32	96.97	96.97	NUM
ijpds-3583	74	33	40	40	NUM
ijpds-3583	74	34	µg	µg	NOUN
ijpds-3583	74	35	/	/	SYM
ijpds-3583	74	36	ml	ml	PROPN
ijpds-3583	74	37	1999120	1999120	NUM
ijpds-3583	74	38	98.04	98.04	NUM
ijpds-3583	74	39	97.88±0.33	97.88±0.33	NUM
ijpds-3583	74	40	1887664	1887664	NUM
ijpds-3583	74	41	97.49	97.49	NUM
ijpds-3583	74	42	1998664	1998664	NUM
ijpds-3583	74	43	98.06	98.06	NUM
ijpds-3583	74	44	table	table	NOUN
ijpds-3583	74	45	8	8	NUM
ijpds-3583	74	46	interday	interday	NOUN
ijpds-3583	74	47	precision	precision	NOUN
ijpds-3583	74	48	study	study	NOUN
ijpds-3583	74	49	of	of	ADP
ijpds-3583	74	50	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	74	51	concentration	concentration	NOUN
ijpds-3583	74	52	in	in	ADP
ijpds-3583	74	53	µg	µg	ADV
ijpds-3583	74	54	/	/	SYM
ijpds-3583	74	55	ml	ml	NOUN
ijpds-3583	74	56	area	area	NOUN
ijpds-3583	74	57	%	%	NOUN
ijpds-3583	74	58	recovery	recovery	NOUN
ijpds-3583	74	59	mean	mean	NOUN
ijpds-3583	74	60	%	%	NOUN
ijpds-3583	74	61	recovery	recovery	NOUN
ijpds-3583	74	62	±	±	NOUN
ijpds-3583	74	63	sd	sd	ADP
ijpds-3583	74	64	mean	mean	ADJ
ijpds-3583	74	65	%	%	NOUN
ijpds-3583	74	66	recovery	recovery	NOUN
ijpds-3583	74	67	±rsd	±rsd	NOUN
ijpds-3583	74	68	3689541	3689541	NUM
ijpds-3583	74	69	97.48	97.48	NUM
ijpds-3583	75	1	97.79±0.354	97.79±0.354	NUM
ijpds-3583	75	2	100	100	NUM
ijpds-3583	75	3	µg	µg	NOUN
ijpds-3583	75	4	/	/	SYM
ijpds-3583	75	5	ml	ml	NOUN
ijpds-3583	75	6	3698627	3698627	NUM
ijpds-3583	75	7	97.73	97.73	NUM
ijpds-3583	75	8	3715496	3715496	NUM
ijpds-3583	75	9	98.18	98.18	NUM
ijpds-3583	75	10	4158946	4158946	NUM
ijpds-3583	75	11	97.89	97.89	NUM
ijpds-3583	75	12	98.62±0.637	98.62±0.637	NUM
ijpds-3583	75	13	122.5	122.5	NUM
ijpds-3583	75	14	µg	µg	NOUN
ijpds-3583	75	15	/	/	SYM
ijpds-3583	75	16	ml	ml	ADP
ijpds-3583	75	17	42011993	42011993	NUM
ijpds-3583	75	18	98.93	98.93	NUM
ijpds-3583	75	19	98.67±0.421	98.67±0.421	PROPN
ijpds-3583	75	20	4207234	4207234	NUM
ijpds-3583	75	21	99.05	99.05	NUM
ijpds-3583	75	22	4699137	4699137	NUM
ijpds-3583	75	23	99.75	99.75	NUM
ijpds-3583	75	24	99.62±0.273	99.62±0.273	NUM
ijpds-3583	75	25	125	125	NUM
ijpds-3583	75	26	µg	µg	NOUN
ijpds-3583	75	27	/	/	SYM
ijpds-3583	75	28	ml	ml	ADP
ijpds-3583	75	29	4678789	4678789	NUM
ijpds-3583	75	30	99.31	99.31	NUM
ijpds-3583	75	31	4701856	4701856	NUM
ijpds-3583	75	32	99.81	99.81	NUM
ijpds-3583	75	33	shaikhmulani	shaikhmulani	NOUN
ijpds-3583	75	34	et	et	PROPN
ijpds-3583	75	35	al	al	PROPN
ijpds-3583	75	36	rp	rp	PROPN
ijpds-3583	75	37	-	-	PUNCT
ijpds-3583	75	38	hplc	hplc	NOUN
ijpds-3583	75	39	method	method	NOUN
ijpds-3583	75	40	development	development	NOUN
ijpds-3583	75	41	and	and	CCONJ
ijpds-3583	75	42	validation	validation	NOUN
ijpds-3583	75	43	of	of	ADP
ijpds-3583	75	44	ben.hcl	ben.hcl	PROPN
ijpds-3583	75	45	&	&	CCONJ
ijpds-3583	75	46	ctd	ctd	PROPN
ijpds-3583	75	47	vol	vol	NOUN
ijpds-3583	75	48	1	1	NUM
ijpds-3583	75	49	|	|	NOUN
ijpds-3583	75	50	issue	issue	NOUN
ijpds-3583	75	51	3	3	NUM
ijpds-3583	75	52	|	|	ADV
ijpds-3583	75	53	oct	oct	PROPN
ijpds-3583	75	54	–	–	PUNCT
ijpds-3583	75	55	dec	dec	PROPN
ijpds-3583	75	56	2022	2022	NUM
ijpds-3583	75	57	indian	indian	PROPN
ijpds-3583	75	58	j	j	PROPN
ijpds-3583	75	59	pharm	pharm	PROPN
ijpds-3583	75	60	drug	drug	PROPN
ijpds-3583	75	61	studies	study	NOUN
ijpds-3583	75	62	|	|	ADV
ijpds-3583	75	63	106	106	NUM
ijpds-3583	75	64	table	table	NOUN
ijpds-3583	75	65	9	9	NUM
ijpds-3583	75	66	recovery	recovery	NOUN
ijpds-3583	75	67	study	study	NOUN
ijpds-3583	75	68	of	of	ADP
ijpds-3583	75	69	benidipine	benidipine	NOUN
ijpds-3583	75	70	hydrochloride	hydrochloride	NOUN
ijpds-3583	75	71	std	std	NOUN
ijpds-3583	75	72	area	area	NOUN
ijpds-3583	75	73	1968846	1968846	NUM
ijpds-3583	75	74	%	%	NOUN
ijpds-3583	75	75	level	level	NOUN
ijpds-3583	75	76	reps	rep	VERB
ijpds-3583	75	77	spiked	spiked	ADJ
ijpds-3583	75	78	conc	conc	NOUN
ijpds-3583	75	79	.	.	PUNCT
ijpds-3583	76	1	(	(	PUNCT
ijpds-3583	76	2	µg	µg	NOUN
ijpds-3583	76	3	/	/	SYM
ijpds-3583	76	4	ml	ml	NOUN
ijpds-3583	76	5	)	)	PUNCT
ijpds-3583	76	6	area	area	NOUN
ijpds-3583	76	7	amount	amount	NOUN
ijpds-3583	76	8	recovered	recover	VERB
ijpds-3583	76	9	µg	µg	ADV
ijpds-3583	76	10	/	/	SYM
ijpds-3583	76	11	ml	ml	NOUN
ijpds-3583	76	12	)	)	PUNCT
ijpds-3583	76	13	%	%	NOUN
ijpds-3583	77	1	recovery	recovery	NOUN
ijpds-3583	77	2	avg	avg	PROPN
ijpds-3583	77	3	stdev	stdev	PROPN
ijpds-3583	77	4	rsd	rsd	PROPN
ijpds-3583	77	5	80	80	NUM
ijpds-3583	77	6	%	%	NOUN
ijpds-3583	77	7	rep	rep	NOUN
ijpds-3583	77	8	1	1	NUM
ijpds-3583	77	9	32	32	NUM
ijpds-3583	77	10	1584314	1584314	NUM
ijpds-3583	77	11	32.19	32.19	NUM
ijpds-3583	77	12	100.59	100.59	NUM
ijpds-3583	77	13	99.86	99.86	NUM
ijpds-3583	77	14	0.702637	0.702637	NUM
ijpds-3583	77	15	0.70	0.70	NUM
ijpds-3583	77	16	rep	rep	NOUN
ijpds-3583	77	17	2	2	NUM
ijpds-3583	77	18	32	32	NUM
ijpds-3583	77	19	1572215	1572215	NUM
ijpds-3583	77	20	31.94	31.94	NUM
ijpds-3583	77	21	99.82	99.82	NUM
ijpds-3583	77	22	rep	rep	NOUN
ijpds-3583	77	23	3	3	NUM
ijpds-3583	77	24	32	32	NUM
ijpds-3583	77	25	1562213	1562213	NUM
ijpds-3583	77	26	31.74	31.74	NUM
ijpds-3583	77	27	99.18	99.18	NUM
ijpds-3583	77	28	100	100	NUM
ijpds-3583	77	29	%	%	NOUN
ijpds-3583	77	30	rep	rep	NOUN
ijpds-3583	77	31	1	1	NUM
ijpds-3583	77	32	40	40	NUM
ijpds-3583	77	33	1979466	1979466	NUM
ijpds-3583	77	34	40.22	40.22	NUM
ijpds-3583	77	35	100.54	100.54	NUM
ijpds-3583	77	36	99.72	99.72	NUM
ijpds-3583	77	37	0.726323	0.726323	NUM
ijpds-3583	77	38	0.73	0.73	NUM
ijpds-3583	77	39	rep	rep	NOUN
ijpds-3583	77	40	2	2	NUM
ijpds-3583	77	41	40	40	NUM
ijpds-3583	77	42	1957783	1957783	NUM
ijpds-3583	77	43	39.78	39.78	NUM
ijpds-3583	77	44	99.44	99.44	NUM
ijpds-3583	77	45	rep	rep	NOUN
ijpds-3583	77	46	3	3	NUM
ijpds-3583	77	47	40	40	NUM
ijpds-3583	77	48	1952473	1952473	NUM
ijpds-3583	77	49	39.67	39.67	NUM
ijpds-3583	77	50	99.17	99.17	NUM
ijpds-3583	77	51	120	120	NUM
ijpds-3583	77	52	%	%	NOUN
ijpds-3583	77	53	rep	rep	NOUN
ijpds-3583	77	54	1	1	NUM
ijpds-3583	77	55	48	48	NUM
ijpds-3583	77	56	2378413	2378413	NUM
ijpds-3583	77	57	48.32	48.32	NUM
ijpds-3583	77	58	100.67	100.67	NUM
ijpds-3583	77	59	99.62	99.62	NUM
ijpds-3583	77	60	1.149973	1.149973	NUM
ijpds-3583	77	61	1.15	1.15	NUM
ijpds-3583	77	62	rep	rep	NOUN
ijpds-3583	77	63	2	2	NUM
ijpds-3583	77	64	48	48	NUM
ijpds-3583	77	65	2324579	2324579	NUM
ijpds-3583	77	66	47.23	47.23	NUM
ijpds-3583	77	67	98.39	98.39	NUM
ijpds-3583	77	68	rep	rep	NOUN
ijpds-3583	77	69	3	3	NUM
ijpds-3583	77	70	48	48	NUM
ijpds-3583	77	71	2357896	2357896	NUM
ijpds-3583	77	72	47.90	47.90	NUM
ijpds-3583	77	73	99.80	99.80	NUM
ijpds-3583	77	74	table	table	NOUN
ijpds-3583	77	75	10	10	NUM
ijpds-3583	77	76	recovery	recovery	NOUN
ijpds-3583	77	77	study	study	NOUN
ijpds-3583	77	78	of	of	ADP
ijpds-3583	77	79	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	77	80	table	table	NOUN
ijpds-3583	77	81	11	11	NUM
ijpds-3583	77	82	system	system	NOUN
ijpds-3583	77	83	suitability	suitability	NOUN
ijpds-3583	77	84	parameters	parameter	NOUN
ijpds-3583	77	85	results	result	NOUN
ijpds-3583	77	86	and	and	CCONJ
ijpds-3583	77	87	discussion	discussion	NOUN
ijpds-3583	77	88	in	in	ADP
ijpds-3583	77	89	this	this	DET
ijpds-3583	77	90	method	method	NOUN
ijpds-3583	77	91	development	development	NOUN
ijpds-3583	77	92	100	100	NUM
ijpds-3583	77	93	ml	ml	NOUN
ijpds-3583	77	94	of	of	ADP
ijpds-3583	77	95	mobile	mobile	ADJ
ijpds-3583	77	96	phase	phase	NOUN
ijpds-3583	77	97	was	be	AUX
ijpds-3583	77	98	prepared	prepare	VERB
ijpds-3583	77	99	by	by	ADP
ijpds-3583	77	100	mixing	mix	VERB
ijpds-3583	77	101	550	550	NUM
ijpds-3583	77	102	ml	ml	NOUN
ijpds-3583	77	103	of	of	ADP
ijpds-3583	77	104	1	1	NUM
ijpds-3583	77	105	%	%	NOUN
ijpds-3583	77	106	orthophosphoric	orthophosphoric	ADJ
ijpds-3583	77	107	acid	acid	NOUN
ijpds-3583	77	108	and	and	CCONJ
ijpds-3583	77	109	450	450	NUM
ijpds-3583	77	110	ml	ml	NOUN
ijpds-3583	77	111	of	of	ADP
ijpds-3583	77	112	methanol	methanol	NOUN
ijpds-3583	77	113	.	.	PUNCT
ijpds-3583	78	1	the	the	DET
ijpds-3583	78	2	mobile	mobile	ADJ
ijpds-3583	78	3	phase	phase	NOUN
ijpds-3583	78	4	filtered	filter	VERB
ijpds-3583	78	5	through	through	ADP
ijpds-3583	78	6	0.45	0.45	NUM
ijpds-3583	78	7	µm	µm	ADP
ijpds-3583	78	8	filters	filter	NOUN
ijpds-3583	78	9	to	to	PART
ijpds-3583	78	10	avoid	avoid	VERB
ijpds-3583	78	11	the	the	DET
ijpds-3583	78	12	column	column	NOUN
ijpds-3583	78	13	clogging	clog	VERB
ijpds-3583	78	14	due	due	ADJ
ijpds-3583	78	15	to	to	ADP
ijpds-3583	78	16	smaller	small	ADJ
ijpds-3583	78	17	particle	particle	NOUN
ijpds-3583	78	18	size	size	NOUN
ijpds-3583	78	19	.	.	PUNCT
ijpds-3583	79	1	the	the	DET
ijpds-3583	79	2	flow	flow	NOUN
ijpds-3583	79	3	rate	rate	NOUN
ijpds-3583	79	4	was	be	AUX
ijpds-3583	79	5	found	find	VERB
ijpds-3583	79	6	to	to	PART
ijpds-3583	79	7	be	be	AUX
ijpds-3583	79	8	1	1	NUM
ijpds-3583	79	9	ml	ml	NOUN
ijpds-3583	79	10	/	/	SYM
ijpds-3583	79	11	min	min	NOUN
ijpds-3583	79	12	resulting	result	VERB
ijpds-3583	79	13	in	in	ADP
ijpds-3583	79	14	short	short	ADJ
ijpds-3583	79	15	retention	retention	NOUN
ijpds-3583	79	16	time	time	NOUN
ijpds-3583	79	17	,	,	PUNCT
ijpds-3583	79	18	good	good	ADJ
ijpds-3583	79	19	baseline	baseline	NOUN
ijpds-3583	79	20	stability	stability	NOUN
ijpds-3583	79	21	with	with	ADP
ijpds-3583	79	22	low	low	ADJ
ijpds-3583	79	23	noise	noise	NOUN
ijpds-3583	79	24	level	level	NOUN
ijpds-3583	79	25	.	.	PUNCT
ijpds-3583	80	1	in	in	ADP
ijpds-3583	80	2	this	this	DET
ijpds-3583	80	3	present	present	NOUN
ijpds-3583	80	4	developed	develop	VERB
ijpds-3583	80	5	rp	rp	NOUN
ijpds-3583	80	6	-	-	PUNCT
ijpds-3583	80	7	hplc	hplc	NOUN
ijpds-3583	80	8	method	method	NOUN
ijpds-3583	80	9	,	,	PUNCT
ijpds-3583	80	10	the	the	DET
ijpds-3583	80	11	standard	standard	NOUN
ijpds-3583	80	12	and	and	CCONJ
ijpds-3583	80	13	sample	sample	NOUN
ijpds-3583	80	14	preparation	preparation	NOUN
ijpds-3583	80	15	required	require	VERB
ijpds-3583	80	16	less	less	ADJ
ijpds-3583	80	17	me	i	PRON
ijpds-3583	80	18	.	.	PUNCT
ijpds-3583	81	1	by	by	ADP
ijpds-3583	81	2	the	the	DET
ijpds-3583	81	3	use	use	NOUN
ijpds-3583	81	4	of	of	ADP
ijpds-3583	81	5	proposed	propose	VERB
ijpds-3583	81	6	method	method	NOUN
ijpds-3583	81	7	the	the	DET
ijpds-3583	81	8	retention	retention	NOUN
ijpds-3583	81	9	time	time	NOUN
ijpds-3583	81	10	of	of	ADP
ijpds-3583	81	11	benidipine	benidipine	NOUN
ijpds-3583	81	12	hydrochloride	hydrochloride	NOUN
ijpds-3583	81	13	and	and	CCONJ
ijpds-3583	81	14	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	81	15	was	be	AUX
ijpds-3583	81	16	found	find	VERB
ijpds-3583	81	17	to	to	PART
ijpds-3583	81	18	be	be	AUX
ijpds-3583	81	19	1.09	1.09	NUM
ijpds-3583	81	20	and	and	CCONJ
ijpds-3583	81	21	3.52	3.52	NUM
ijpds-3583	81	22	minutes	minute	NOUN
ijpds-3583	81	23	respectively	respectively	ADV
ijpds-3583	81	24	.	.	PUNCT
ijpds-3583	82	1	table	table	NOUN
ijpds-3583	82	2	12	12	NUM
ijpds-3583	82	3	specificity	specificity	NOUN
ijpds-3583	82	4	parameter	parameter	NOUN
ijpds-3583	82	5	parameter	parameter	PROPN
ijpds-3583	82	6	benidipine	benidipine	PROPN
ijpds-3583	82	7	hydrochloride	hydrochloride	NOUN
ijpds-3583	82	8	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	82	9	tailing	tail	VERB
ijpds-3583	82	10	factor	factor	NOUN
ijpds-3583	82	11	1.09	1.09	NUM
ijpds-3583	82	12	1.05	1.05	NUM
ijpds-3583	82	13	resolution	resolution	NOUN
ijpds-3583	82	14	0.00	0.00	NUM
ijpds-3583	82	15	9.62	9.62	NUM
ijpds-3583	82	16	retention	retention	NOUN
ijpds-3583	82	17	time	time	NOUN
ijpds-3583	82	18	1.09	1.09	NUM
ijpds-3583	82	19	3.52	3.52	NUM
ijpds-3583	82	20	the	the	DET
ijpds-3583	82	21	assay	assay	NOUN
ijpds-3583	82	22	of	of	ADP
ijpds-3583	82	23	benidipine	benidipine	NOUN
ijpds-3583	82	24	hydrochloride	hydrochloride	NOUN
ijpds-3583	82	25	and	and	CCONJ
ijpds-3583	82	26	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	82	27	in	in	ADP
ijpds-3583	82	28	bulk	bulk	ADJ
ijpds-3583	82	29	drug	drug	NOUN
ijpds-3583	82	30	and	and	CCONJ
ijpds-3583	82	31	combined	combine	VERB
ijpds-3583	82	32	dosage	dosage	NOUN
ijpds-3583	82	33	form	form	NOUN
ijpds-3583	82	34	was	be	AUX
ijpds-3583	82	35	found	find	VERB
ijpds-3583	82	36	to	to	PART
ijpds-3583	82	37	be	be	AUX
ijpds-3583	82	38	100.99	100.99	NUM
ijpds-3583	82	39	%	%	NOUN
ijpds-3583	82	40	and	and	CCONJ
ijpds-3583	82	41	100.15	100.15	NUM
ijpds-3583	82	42	%	%	NOUN
ijpds-3583	82	43	respectively	respectively	ADV
ijpds-3583	82	44	.	.	PUNCT
ijpds-3583	83	1	a	a	DET
ijpds-3583	83	2	good	good	ADJ
ijpds-3583	83	3	linear	linear	PROPN
ijpds-3583	83	4	relationship	relationship	NOUN
ijpds-3583	83	5	,	,	PUNCT
ijpds-3583	83	6	r2	r2	PROPN
ijpds-3583	83	7	=	=	PUNCT
ijpds-3583	83	8	0.999	0.999	NUM
ijpds-3583	83	9	for	for	ADP
ijpds-3583	83	10	benidipine	benidipine	NOUN
ijpds-3583	83	11	hydrochloride	hydrochloride	NOUN
ijpds-3583	83	12	and	and	CCONJ
ijpds-3583	83	13	r2	r2	NOUN
ijpds-3583	83	14	=	=	PUNCT
ijpds-3583	83	15	0.999	0.999	NUM
ijpds-3583	83	16	for	for	ADP
ijpds-3583	83	17	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	83	18	was	be	AUX
ijpds-3583	83	19	observed	observe	VERB
ijpds-3583	83	20	between	between	ADP
ijpds-3583	83	21	the	the	DET
ijpds-3583	83	22	concentration	concentration	NOUN
ijpds-3583	83	23	range	range	NOUN
ijpds-3583	83	24	of	of	ADP
ijpds-3583	83	25	32	32	NUM
ijpds-3583	83	26	-	-	PUNCT
ijpds-3583	83	27	48µg	48µg	NOUN
ijpds-3583	83	28	/	/	SYM
ijpds-3583	83	29	ml	ml	NOUN
ijpds-3583	83	30	and	and	CCONJ
ijpds-3583	83	31	100	100	NUM
ijpds-3583	83	32	-	-	PUNCT
ijpds-3583	83	33	150µg	150µg	NOUN
ijpds-3583	83	34	/	/	SYM
ijpds-3583	83	35	ml	ml	NOUN
ijpds-3583	83	36	,	,	PUNCT
ijpds-3583	83	37	respectively	respectively	ADV
ijpds-3583	83	38	.	.	PUNCT
ijpds-3583	84	1	the	the	DET
ijpds-3583	84	2	lod	lod	PROPN
ijpds-3583	84	3	and	and	CCONJ
ijpds-3583	84	4	loq	loq	PROPN
ijpds-3583	84	5	values	value	NOUN
ijpds-3583	84	6	for	for	ADP
ijpds-3583	84	7	benidipine	benidipine	NOUN
ijpds-3583	84	8	hydrochloride	hydrochloride	NOUN
ijpds-3583	84	9	was	be	AUX
ijpds-3583	84	10	found	find	VERB
ijpds-3583	84	11	to	to	PART
ijpds-3583	84	12	be	be	AUX
ijpds-3583	84	13	2.05µg	2.05µg	NUM
ijpds-3583	84	14	/	/	SYM
ijpds-3583	84	15	ml	ml	NOUN
ijpds-3583	84	16	and	and	CCONJ
ijpds-3583	84	17	6.22	6.22	NUM
ijpds-3583	84	18	µg	µg	NOUN
ijpds-3583	84	19	/	/	SYM
ijpds-3583	84	20	ml	ml	NOUN
ijpds-3583	84	21	and	and	CCONJ
ijpds-3583	84	22	for	for	ADP
ijpds-3583	84	23	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	84	24	7.71	7.71	NUM
ijpds-3583	84	25	µg	µg	NOUN
ijpds-3583	84	26	/	/	SYM
ijpds-3583	84	27	ml	ml	NOUN
ijpds-3583	84	28	and	and	CCONJ
ijpds-3583	84	29	23.38	23.38	NUM
ijpds-3583	84	30	µg	µg	NOUN
ijpds-3583	84	31	/	/	SYM
ijpds-3583	84	32	ml	ml	NOUN
ijpds-3583	84	33	,	,	PUNCT
ijpds-3583	84	34	respectively	respectively	ADV
ijpds-3583	84	35	.	.	PUNCT
ijpds-3583	85	1	the	the	DET
ijpds-3583	85	2	low	low	ADJ
ijpds-3583	85	3	values	value	NOUN
ijpds-3583	85	4	of	of	ADP
ijpds-3583	85	5	standard	standard	ADJ
ijpds-3583	85	6	deviation	deviation	NOUN
ijpds-3583	85	7	of	of	ADP
ijpds-3583	85	8	retention	retention	NOUN
ijpds-3583	85	9	time	time	NOUN
ijpds-3583	85	10	and	and	CCONJ
ijpds-3583	85	11	peak	peak	NOUN
ijpds-3583	85	12	area	area	NOUN
ijpds-3583	85	13	indicates	indicate	VERB
ijpds-3583	85	14	high	high	ADJ
ijpds-3583	85	15	precision	precision	NOUN
ijpds-3583	85	16	of	of	ADP
ijpds-3583	85	17	method	method	NOUN
ijpds-3583	85	18	from	from	ADP
ijpds-3583	85	19	recovery	recovery	NOUN
ijpds-3583	85	20	study	study	NOUN
ijpds-3583	85	21	data	datum	NOUN
ijpds-3583	85	22	it	it	PRON
ijpds-3583	85	23	has	have	AUX
ijpds-3583	85	24	found	find	VERB
ijpds-3583	85	25	to	to	PART
ijpds-3583	85	26	be	be	AUX
ijpds-3583	85	27	mean	mean	ADJ
ijpds-3583	85	28	%	%	NOUN
ijpds-3583	85	29	recovery	recovery	NOUN
ijpds-3583	85	30	was	be	AUX
ijpds-3583	85	31	within	within	ADP
ijpds-3583	85	32	a	a	DET
ijpds-3583	85	33	limit	limit	NOUN
ijpds-3583	85	34	,	,	PUNCT
ijpds-3583	85	35	indicates	indicate	VERB
ijpds-3583	85	36	high	high	ADJ
ijpds-3583	85	37	accuracy	accuracy	NOUN
ijpds-3583	85	38	of	of	ADP
ijpds-3583	85	39	proposed	propose	VERB
ijpds-3583	85	40	method	method	NOUN
ijpds-3583	85	41	.	.	PUNCT
ijpds-3583	86	1	there	there	PRON
ijpds-3583	86	2	are	be	VERB
ijpds-3583	86	3	no	no	DET
ijpds-3583	86	4	additional	additional	ADJ
ijpds-3583	86	5	peaks	peak	NOUN
ijpds-3583	86	6	are	be	AUX
ijpds-3583	86	7	observed	observe	VERB
ijpds-3583	86	8	in	in	ADP
ijpds-3583	86	9	the	the	DET
ijpds-3583	86	10	chromatogram	chromatogram	NOUN
ijpds-3583	86	11	which	which	PRON
ijpds-3583	86	12	indicates	indicate	VERB
ijpds-3583	86	13	no	no	DET
ijpds-3583	86	14	interference	interference	NOUN
ijpds-3583	86	15	of	of	ADP
ijpds-3583	86	16	common	common	ADJ
ijpds-3583	86	17	ingredients	ingredient	NOUN
ijpds-3583	86	18	used	use	VERB
ijpds-3583	86	19	in	in	ADP
ijpds-3583	86	20	formulation	formulation	NOUN
ijpds-3583	86	21	.	.	PUNCT
ijpds-3583	87	1	no	no	DET
ijpds-3583	87	2	marked	mark	VERB
ijpds-3583	87	3	changes	change	NOUN
ijpds-3583	87	4	were	be	AUX
ijpds-3583	87	5	observed	observe	VERB
ijpds-3583	87	6	in	in	ADP
ijpds-3583	87	7	%	%	NOUN
ijpds-3583	87	8	assay	assay	NOUN
ijpds-3583	87	9	of	of	ADP
ijpds-3583	87	10	the	the	DET
ijpds-3583	87	11	optimized	optimize	VERB
ijpds-3583	87	12	condition	condition	NOUN
ijpds-3583	87	13	with	with	ADP
ijpds-3583	87	14	that	that	PRON
ijpds-3583	87	15	of	of	ADP
ijpds-3583	87	16	alternate	alternate	ADJ
ijpds-3583	87	17	condition	condition	NOUN
ijpds-3583	87	18	in	in	ADP
ijpds-3583	87	19	the	the	DET
ijpds-3583	87	20	robustness	robustness	NOUN
ijpds-3583	87	21	study	study	NOUN
ijpds-3583	87	22	indicating	indicate	VERB
ijpds-3583	87	23	that	that	SCONJ
ijpds-3583	87	24	the	the	DET
ijpds-3583	87	25	method	method	NOUN
ijpds-3583	87	26	is	be	AUX
ijpds-3583	87	27	robust	robust	ADJ
ijpds-3583	87	28	.	.	PUNCT
ijpds-3583	88	1	std	std	NOUN
ijpds-3583	88	2	area	area	NOUN
ijpds-3583	88	3	4735952	4735952	NUM
ijpds-3583	88	4	%	%	NOUN
ijpds-3583	88	5	level	level	NOUN
ijpds-3583	88	6	reps	rep	VERB
ijpds-3583	88	7	spiked	spiked	ADJ
ijpds-3583	88	8	conc	conc	NOUN
ijpds-3583	88	9	.	.	PUNCT
ijpds-3583	89	1	µg	µg	VERB
ijpds-3583	89	2	/	/	SYM
ijpds-3583	89	3	ml	ml	NOUN
ijpds-3583	89	4	)	)	PUNCT
ijpds-3583	89	5	area	area	NOUN
ijpds-3583	89	6	amount	amount	NOUN
ijpds-3583	89	7	recovered	recover	VERB
ijpds-3583	89	8	(	(	PUNCT
ijpds-3583	89	9	µg	µg	NOUN
ijpds-3583	89	10	/	/	SYM
ijpds-3583	89	11	ml	ml	NOUN
ijpds-3583	89	12	)	)	PUNCT
ijpds-3583	89	13	%	%	NOUN
ijpds-3583	90	1	recovery	recovery	NOUN
ijpds-3583	90	2	avg	avg	PROPN
ijpds-3583	90	3	stdev	stdev	PROPN
ijpds-3583	90	4	rsd	rsd	PROPN
ijpds-3583	90	5	80	80	NUM
ijpds-3583	90	6	%	%	NOUN
ijpds-3583	90	7	rep	rep	NOUN
ijpds-3583	90	8	1	1	NUM
ijpds-3583	90	9	100	100	NUM
ijpds-3583	90	10	3800057	3800057	NUM
ijpds-3583	90	11	100.30	100.30	NUM
ijpds-3583	90	12	100.30	100.30	NUM
ijpds-3583	90	13	100.58	100.58	NUM
ijpds-3583	90	14	0.282482	0.282482	NUM
ijpds-3583	90	15	0.28	0.28	NUM
ijpds-3583	90	16	rep	rep	NOUN
ijpds-3583	90	17	2	2	NUM
ijpds-3583	90	18	100	100	NUM
ijpds-3583	90	19	3821454	3821454	NUM
ijpds-3583	90	20	100.86	100.86	NUM
ijpds-3583	90	21	100.86	100.86	NUM
ijpds-3583	90	22	rep	rep	NOUN
ijpds-3583	90	23	3	3	NUM
ijpds-3583	90	24	100	100	NUM
ijpds-3583	90	25	3810244	3810244	NUM
ijpds-3583	90	26	100.57	100.57	NUM
ijpds-3583	90	27	100.57	100.57	NUM
ijpds-3583	90	28	100	100	NUM
ijpds-3583	90	29	%	%	NOUN
ijpds-3583	90	30	rep	rep	NOUN
ijpds-3583	90	31	1	1	NUM
ijpds-3583	90	32	125	125	NUM
ijpds-3583	90	33	4721514	4721514	NUM
ijpds-3583	90	34	124.62	124.62	NUM
ijpds-3583	90	35	99.70	99.70	NUM
ijpds-3583	90	36	100.06	100.06	NUM
ijpds-3583	90	37	0.444878	0.444878	NUM
ijpds-3583	90	38	0.44	0.44	NUM
ijpds-3583	90	39	rep	rep	NOUN
ijpds-3583	90	40	2	2	NUM
ijpds-3583	90	41	125	125	NUM
ijpds-3583	90	42	4732156	4732156	NUM
ijpds-3583	90	43	124.90	124.90	NUM
ijpds-3583	90	44	99.92	99.92	NUM
ijpds-3583	90	45	rep	rep	NOUN
ijpds-3583	90	46	3	3	NUM
ijpds-3583	90	47	125	125	NUM
ijpds-3583	90	48	4762145	4762145	NUM
ijpds-3583	90	49	125.69	125.69	NUM
ijpds-3583	90	50	100.55	100.55	NUM
ijpds-3583	90	51	120	120	NUM
ijpds-3583	90	52	%	%	NOUN
ijpds-3583	90	53	rep	rep	NOUN
ijpds-3583	90	54	1	1	NUM
ijpds-3583	90	55	150	150	NUM
ijpds-3583	90	56	5626385	5626385	NUM
ijpds-3583	90	57	148.50	148.50	NUM
ijpds-3583	90	58	99.00	99.00	NUM
ijpds-3583	90	59	98.96	98.96	NUM
ijpds-3583	90	60	0.047238	0.047238	NUM
ijpds-3583	90	61	0.05	0.05	NUM
ijpds-3583	90	62	rep	rep	NOUN
ijpds-3583	90	63	2	2	NUM
ijpds-3583	90	64	150	150	NUM
ijpds-3583	90	65	5621020	5621020	NUM
ijpds-3583	90	66	148.36	148.36	NUM
ijpds-3583	90	67	98.91	98.91	NUM
ijpds-3583	90	68	rep	rep	NOUN
ijpds-3583	90	69	3	3	NUM
ijpds-3583	90	70	150	150	NUM
ijpds-3583	90	71	5623887	5623887	NUM
ijpds-3583	90	72	148.44	148.44	NUM
ijpds-3583	90	73	98.96	98.96	NUM
ijpds-3583	90	74	sr.no	sr.no	NOUN
ijpds-3583	90	75	parameters	parameter	NOUN
ijpds-3583	90	76	benidipine	benidipine	VERB
ijpds-3583	90	77	hydrochloride	hydrochloride	NOUN
ijpds-3583	90	78	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	90	79	1	1	NUM
ijpds-3583	90	80	retention	retention	NOUN
ijpds-3583	90	81	time	time	NOUN
ijpds-3583	90	82	(	(	PUNCT
ijpds-3583	90	83	rt	rt	NOUN
ijpds-3583	90	84	)	)	PUNCT
ijpds-3583	90	85	1.09	1.09	NUM
ijpds-3583	90	86	3.52	3.52	NUM
ijpds-3583	90	87	2	2	NUM
ijpds-3583	90	88	area	area	NOUN
ijpds-3583	90	89	1979466	1979466	NUM
ijpds-3583	90	90	4731515	4731515	NUM
ijpds-3583	90	91	3	3	NUM
ijpds-3583	90	92	theoretical	theoretical	ADJ
ijpds-3583	90	93	plates	plate	NOUN
ijpds-3583	90	94	5344	5344	NUM
ijpds-3583	90	95	8346	8346	NUM
ijpds-3583	90	96	4	4	NUM
ijpds-3583	90	97	resolution	resolution	NOUN
ijpds-3583	90	98	0.0	0.0	NUM
ijpds-3583	90	99	9.62	9.62	NUM
ijpds-3583	90	100	shaikhmulani	shaikhmulani	NOUN
ijpds-3583	90	101	et	et	PROPN
ijpds-3583	90	102	al	al	PROPN
ijpds-3583	90	103	rp	rp	PROPN
ijpds-3583	90	104	-	-	PUNCT
ijpds-3583	90	105	hplc	hplc	NOUN
ijpds-3583	90	106	method	method	NOUN
ijpds-3583	90	107	development	development	NOUN
ijpds-3583	90	108	and	and	CCONJ
ijpds-3583	90	109	validation	validation	NOUN
ijpds-3583	90	110	of	of	ADP
ijpds-3583	90	111	ben.hcl	ben.hcl	PROPN
ijpds-3583	90	112	&	&	CCONJ
ijpds-3583	90	113	ctd	ctd	PROPN
ijpds-3583	90	114	vol	vol	NOUN
ijpds-3583	90	115	1	1	NUM
ijpds-3583	90	116	|	|	NOUN
ijpds-3583	90	117	issue	issue	NOUN
ijpds-3583	90	118	3	3	NUM
ijpds-3583	90	119	|	|	ADV
ijpds-3583	90	120	oct	oct	PROPN
ijpds-3583	90	121	–	–	PUNCT
ijpds-3583	90	122	dec	dec	PROPN
ijpds-3583	90	123	2022	2022	NUM
ijpds-3583	90	124	indian	indian	PROPN
ijpds-3583	90	125	j	j	PROPN
ijpds-3583	90	126	pharm	pharm	PROPN
ijpds-3583	90	127	drug	drug	PROPN
ijpds-3583	90	128	studies	study	NOUN
ijpds-3583	90	129	|	|	ADV
ijpds-3583	90	130	107	107	NUM
ijpds-3583	90	131	table	table	NOUN
ijpds-3583	90	132	13	13	NUM
ijpds-3583	90	133	lod	lod	PROPN
ijpds-3583	90	134	&	&	CCONJ
ijpds-3583	90	135	loq	loq	PROPN
ijpds-3583	90	136	parameter	parameter	PROPN
ijpds-3583	90	137	name	name	NOUN
ijpds-3583	90	138	of	of	ADP
ijpds-3583	90	139	drug	drug	NOUN
ijpds-3583	90	140	lod	lod	PROPN
ijpds-3583	90	141	(	(	PUNCT
ijpds-3583	90	142	µg	µg	NOUN
ijpds-3583	90	143	/	/	SYM
ijpds-3583	90	144	ml	ml	NOUN
ijpds-3583	90	145	)	)	PUNCT
ijpds-3583	90	146	loq	loq	PROPN
ijpds-3583	90	147	(	(	PUNCT
ijpds-3583	90	148	µg	µg	NOUN
ijpds-3583	90	149	/	/	SYM
ijpds-3583	90	150	ml	ml	NOUN
ijpds-3583	90	151	)	)	PUNCT
ijpds-3583	90	152	benidipine	benidipine	NOUN
ijpds-3583	90	153	hydrochloride	hydrochloride	NOUN
ijpds-3583	90	154	2.05	2.05	NUM
ijpds-3583	90	155	6.22	6.22	NUM
ijpds-3583	90	156	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	90	157	7.71	7.71	NUM
ijpds-3583	90	158	23.38	23.38	NUM
ijpds-3583	90	159	conclusion	conclusion	NOUN
ijpds-3583	90	160	a	a	DET
ijpds-3583	90	161	simple	simple	ADJ
ijpds-3583	90	162	competent	competent	ADJ
ijpds-3583	90	163	method	method	NOUN
ijpds-3583	90	164	was	be	AUX
ijpds-3583	90	165	developed	develop	VERB
ijpds-3583	90	166	for	for	ADP
ijpds-3583	90	167	the	the	DET
ijpds-3583	90	168	simultaneous	simultaneous	ADJ
ijpds-3583	90	169	equation	equation	NOUN
ijpds-3583	90	170	of	of	ADP
ijpds-3583	90	171	benidipine	benidipine	NOUN
ijpds-3583	90	172	hydrochloride	hydrochloride	NOUN
ijpds-3583	90	173	and	and	CCONJ
ijpds-3583	90	174	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	90	175	within	within	ADP
ijpds-3583	90	176	a	a	DET
ijpds-3583	90	177	short	short	ADJ
ijpds-3583	90	178	analysis	analysis	NOUN
ijpds-3583	90	179	time	time	NOUN
ijpds-3583	90	180	with	with	ADP
ijpds-3583	90	181	no	no	DET
ijpds-3583	90	182	interference	interference	NOUN
ijpds-3583	90	183	of	of	ADP
ijpds-3583	90	184	common	common	ADJ
ijpds-3583	90	185	additives	additive	NOUN
ijpds-3583	90	186	present	present	ADJ
ijpds-3583	90	187	in	in	ADP
ijpds-3583	90	188	tablet	tablet	ADJ
ijpds-3583	90	189	formulation	formulation	NOUN
ijpds-3583	90	190	.	.	PUNCT
ijpds-3583	91	1	the	the	DET
ijpds-3583	91	2	proposed	propose	VERB
ijpds-3583	91	3	method	method	NOUN
ijpds-3583	91	4	can	can	AUX
ijpds-3583	91	5	be	be	AUX
ijpds-3583	91	6	applied	apply	VERB
ijpds-3583	91	7	for	for	ADP
ijpds-3583	91	8	routine	routine	ADJ
ijpds-3583	91	9	quality	quality	NOUN
ijpds-3583	91	10	control	control	NOUN
ijpds-3583	91	11	and	and	CCONJ
ijpds-3583	91	12	applied	apply	VERB
ijpds-3583	91	13	for	for	ADP
ijpds-3583	91	14	bulk	bulk	NOUN
ijpds-3583	91	15	and	and	CCONJ
ijpds-3583	91	16	in	in	ADP
ijpds-3583	91	17	tablet	tablet	ADJ
ijpds-3583	91	18	dosage	dosage	NOUN
ijpds-3583	91	19	form	form	NOUN
ijpds-3583	91	20	.	.	PUNCT
ijpds-3583	92	1	references	reference	NOUN
ijpds-3583	92	2	1	1	NUM
ijpds-3583	92	3	.	.	PUNCT
ijpds-3583	93	1	wikipedia	wikipedia	PROPN
ijpds-3583	93	2	contributors	contributors	PROPN
ijpds-3583	93	3	.	.	PUNCT
ijpds-3583	94	1	benidipine	benidipine	PROPN
ijpds-3583	95	1	[	[	X
ijpds-3583	95	2	internet	internet	NOUN
ijpds-3583	95	3	]	]	PUNCT
ijpds-3583	95	4	.	.	PUNCT
ijpds-3583	96	1	wikipedia	wikipedia	PROPN
ijpds-3583	96	2	,	,	PUNCT
ijpds-3583	96	3	the	the	DET
ijpds-3583	96	4	free	free	ADJ
ijpds-3583	96	5	encyclopedia	encyclopedia	NOUN
ijpds-3583	96	6	.	.	PUNCT
ijpds-3583	96	7	available	available	ADJ
ijpds-3583	96	8	from	from	ADP
ijpds-3583	96	9	:	:	PUNCT
ijpds-3583	96	10	https://en.m.wikipedia.org/wiki/benidipine	https://en.m.wikipedia.org/wiki/benidipine	PROPN
ijpds-3583	96	11	2	2	NUM
ijpds-3583	96	12	.	.	PUNCT
ijpds-3583	96	13	drugbank.com	drugbank.com	X
ijpds-3583	96	14	.	.	PUNCT
ijpds-3583	97	1	[	[	X
ijpds-3583	97	2	cited	cite	VERB
ijpds-3583	97	3	2022	2022	NUM
ijpds-3583	97	4	jul	jul	PROPN
ijpds-3583	97	5	28	28	NUM
ijpds-3583	97	6	]	]	PUNCT
ijpds-3583	97	7	.	.	PUNCT
ijpds-3583	98	1	available	available	ADJ
ijpds-3583	98	2	from	from	ADP
ijpds-3583	98	3	:	:	PUNCT
ijpds-3583	98	4	https://engo.drugbank.com/drug/db09231	https://engo.drugbank.com/drug/db09231	PROPN
ijpds-3583	98	5	3	3	X
ijpds-3583	98	6	.	.	X
ijpds-3583	98	7	tripathi	tripathi	PROPN
ijpds-3583	98	8	k.d	k.d	PROPN
ijpds-3583	98	9	,	,	PUNCT
ijpds-3583	98	10	essential	essential	ADJ
ijpds-3583	98	11	of	of	ADP
ijpds-3583	98	12	medical	medical	ADJ
ijpds-3583	98	13	pharmacology	pharmacology	NOUN
ijpds-3583	98	14	7th	7th	PROPN
ijpds-3583	98	15	edition	edition	PROPN
ijpds-3583	98	16	jaypee	jaypee	PROPN
ijpds-3583	98	17	brother	brother	PROPN
ijpds-3583	98	18	’s	’s	PART
ijpds-3583	98	19	medical	medical	ADJ
ijpds-3583	98	20	publishers	publisher	NOUN
ijpds-3583	98	21	,	,	PUNCT
ijpds-3583	98	22	new	new	ADJ
ijpds-3583	98	23	delhi	delhi	PROPN
ijpds-3583	98	24	p.n-549	p.n-549	PROPN
ijpds-3583	98	25	-	-	PUNCT
ijpds-3583	98	26	551	551	NUM
ijpds-3583	98	27	.	.	PUNCT
ijpds-3583	99	1	4	4	NUM
ijpds-3583	99	2	.	.	X
ijpds-3583	99	3	wikipedia	wikipedia	PROPN
ijpds-3583	99	4	contributors	contributors	PROPN
ijpds-3583	99	5	.	.	PUNCT
ijpds-3583	100	1	chlortalidone	chlortalidone	PROPN
ijpds-3583	101	1	[	[	X
ijpds-3583	101	2	internet	internet	NOUN
ijpds-3583	101	3	]	]	PUNCT
ijpds-3583	101	4	.	.	PUNCT
ijpds-3583	102	1	wikipedia	wikipedia	PROPN
ijpds-3583	102	2	,	,	PUNCT
ijpds-3583	102	3	the	the	DET
ijpds-3583	102	4	free	free	ADJ
ijpds-3583	102	5	encyclopedia	encyclopedia	NOUN
ijpds-3583	102	6	.	.	PUNCT
ijpds-3583	102	7	available	available	ADJ
ijpds-3583	102	8	from	from	ADP
ijpds-3583	102	9	:	:	PUNCT
ijpds-3583	102	10	https://en.m.wikipedia.org/wiki/chlorthalidone	https://en.m.wikipedia.org/wiki/chlorthalidone	NOUN
ijpds-3583	102	11	5	5	NUM
ijpds-3583	102	12	.	.	PUNCT
ijpds-3583	102	13	tripathi	tripathi	PROPN
ijpds-3583	102	14	k.d	k.d	PROPN
ijpds-3583	102	15	,	,	PUNCT
ijpds-3583	102	16	essential	essential	ADJ
ijpds-3583	102	17	of	of	ADP
ijpds-3583	102	18	medical	medical	ADJ
ijpds-3583	102	19	pharmacology	pharmacology	NOUN
ijpds-3583	102	20	7th	7th	PROPN
ijpds-3583	102	21	edition	edition	PROPN
ijpds-3583	102	22	jaypee	jaypee	PROPN
ijpds-3583	102	23	brothers	brothers	PROPN
ijpds-3583	102	24	medical	medical	ADJ
ijpds-3583	102	25	publishers	publisher	NOUN
ijpds-3583	102	26	,	,	PUNCT
ijpds-3583	102	27	new	new	ADJ
ijpds-3583	102	28	delhi	delhi	ADJ
ijpds-3583	102	29	p.n.559	p.n.559	PROPN
ijpds-3583	102	30	-	-	SYM
ijpds-3583	102	31	560	560	NUM
ijpds-3583	102	32	6	6	NUM
ijpds-3583	102	33	.	.	PUNCT
ijpds-3583	103	1	chaudhary	chaudhary	PROPN
ijpds-3583	103	2	br	br	PROPN
ijpds-3583	103	3	.	.	PUNCT
ijpds-3583	103	4	development	development	NOUN
ijpds-3583	103	5	and	and	CCONJ
ijpds-3583	103	6	validation	validation	NOUN
ijpds-3583	103	7	of	of	ADP
ijpds-3583	103	8	stability	stability	NOUN
ijpds-3583	103	9	indicating	indicate	VERB
ijpds-3583	103	10	gradient	gradient	ADJ
ijpds-3583	103	11	rp	rp	NOUN
ijpds-3583	103	12	-	-	PUNCT
ijpds-3583	103	13	hplc	hplc	NOUN
ijpds-3583	103	14	method	method	NOUN
ijpds-3583	103	15	for	for	ADP
ijpds-3583	103	16	simultaneous	simultaneous	ADJ
ijpds-3583	103	17	estimation	estimation	NOUN
ijpds-3583	103	18	of	of	ADP
ijpds-3583	103	19	telmisartan	telmisartan	NOUN
ijpds-3583	103	20	and	and	CCONJ
ijpds-3583	103	21	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	103	22	in	in	ADP
ijpds-3583	103	23	bulk	bulk	ADJ
ijpds-3583	103	24	api	api	NOUN
ijpds-3583	103	25	and	and	CCONJ
ijpds-3583	103	26	fixed	fix	VERB
ijpds-3583	103	27	dose	dose	NOUN
ijpds-3583	103	28	combination	combination	NOUN
ijpds-3583	103	29	.	.	PUNCT
ijpds-3583	104	1	world	world	PROPN
ijpds-3583	104	2	j	j	PROPN
ijpds-3583	104	3	pharm	pharm	PROPN
ijpds-3583	104	4	res	re	VERB
ijpds-3583	104	5	[	[	X
ijpds-3583	104	6	internet	internet	NOUN
ijpds-3583	104	7	]	]	PUNCT
ijpds-3583	104	8	.	.	PUNCT
ijpds-3583	105	1	2017	2017	NUM
ijpds-3583	105	2	;	;	PUNCT
ijpds-3583	105	3	1015	1015	NUM
ijpds-3583	105	4	29	29	NUM
ijpds-3583	105	5	.	.	PUNCT
ijpds-3583	106	1	available	available	ADJ
ijpds-3583	106	2	from	from	ADP
ijpds-3583	106	3	:	:	PUNCT
ijpds-3583	106	4	http://dx.doi.org/10.20959/wjpr201710-9417	http://dx.doi.org/10.20959/wjpr201710-9417	PROPN
ijpds-3583	106	5	7	7	X
ijpds-3583	106	6	.	.	PUNCT
ijpds-3583	106	7	bhoomi	bhoomi	PROPN
ijpds-3583	107	1	d	d	PROPN
ijpds-3583	107	2	patel	patel	PROPN
ijpds-3583	107	3	,	,	PUNCT
ijpds-3583	107	4	ankit	ankit	PROPN
ijpds-3583	107	5	chaudhary	chaudhary	PROPN
ijpds-3583	107	6	,	,	PUNCT
ijpds-3583	107	7	sudhir	sudhir	PROPN
ijpds-3583	107	8	gam	gam	PROPN
ijpds-3583	107	9	.	.	PUNCT
ijpds-3583	107	10	rphplc	rphplc	PROPN
ijpds-3583	107	11	method	method	PROPN
ijpds-3583	107	12	development	development	NOUN
ijpds-3583	107	13	and	and	CCONJ
ijpds-3583	107	14	validation	validation	NOUN
ijpds-3583	107	15	for	for	ADP
ijpds-3583	107	16	simultaneous	simultaneous	ADJ
ijpds-3583	107	17	estimation	estimation	NOUN
ijpds-3583	107	18	of	of	ADP
ijpds-3583	107	19	benidipine	benidipine	NOUN
ijpds-3583	107	20	hydrochloride	hydrochloride	NOUN
ijpds-3583	107	21	,	,	PUNCT
ijpds-3583	107	22	telmisartan	telmisartan	NOUN
ijpds-3583	107	23	and	and	CCONJ
ijpds-3583	107	24	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	107	25	in	in	ADP
ijpds-3583	107	26	tablet	tablet	ADJ
ijpds-3583	107	27	dosage	dosage	NOUN
ijpds-3583	107	28	form	form	NOUN
ijpds-3583	107	29	,	,	PUNCT
ijpds-3583	107	30	journal	journal	NOUN
ijpds-3583	107	31	of	of	ADP
ijpds-3583	107	32	emerging	emerge	VERB
ijpds-3583	107	33	technologies	technology	NOUN
ijpds-3583	107	34	and	and	CCONJ
ijpds-3583	107	35	innovative	innovative	ADJ
ijpds-3583	107	36	research	research	NOUN
ijpds-3583	107	37	,	,	PUNCT
ijpds-3583	107	38	6(3	6(3	NUM
ijpds-3583	107	39	)	)	PUNCT
ijpds-3583	107	40	2019	2019	NUM
ijpds-3583	107	41	,	,	PUNCT
ijpds-3583	107	42	110	110	NUM
ijpds-3583	107	43	124	124	NUM
ijpds-3583	107	44	8	8	NUM
ijpds-3583	107	45	.	.	PUNCT
ijpds-3583	108	1	vhanmane	vhanmane	PROPN
ijpds-3583	108	2	a	a	PRON
ijpds-3583	108	3	,	,	PUNCT
ijpds-3583	108	4	tamboli	tamboli	NOUN
ijpds-3583	108	5	a	a	PRON
ijpds-3583	108	6	,	,	PUNCT
ijpds-3583	108	7	more	more	ADJ
ijpds-3583	108	8	s.	s.	PROPN
ijpds-3583	108	9	rp	rp	PROPN
ijpds-3583	108	10	-	-	PUNCT
ijpds-3583	108	11	hplc	hplc	NOUN
ijpds-3583	108	12	method	method	NOUN
ijpds-3583	108	13	development	development	NOUN
ijpds-3583	108	14	and	and	CCONJ
ijpds-3583	108	15	validation	validation	NOUN
ijpds-3583	108	16	for	for	ADP
ijpds-3583	108	17	the	the	DET
ijpds-3583	108	18	simultaneous	simultaneous	ADJ
ijpds-3583	108	19	estimation	estimation	NOUN
ijpds-3583	108	20	of	of	ADP
ijpds-3583	108	21	gabapentin	gabapentin	NOUN
ijpds-3583	108	22	and	and	CCONJ
ijpds-3583	108	23	amitriptyline	amitriptyline	NOUN
ijpds-3583	108	24	hydrochloride	hydrochloride	NOUN
ijpds-3583	108	25	in	in	ADP
ijpds-3583	108	26	pharmaceutical	pharmaceutical	ADJ
ijpds-3583	108	27	dosage	dosage	NOUN
ijpds-3583	108	28	forms	form	NOUN
ijpds-3583	108	29	.	.	PUNCT
ijpds-3583	109	1	jddt	jddt	ADJ
ijpds-3583	110	1	[	[	X
ijpds-3583	110	2	internet	internet	NOUN
ijpds-3583	110	3	]	]	X
ijpds-3583	110	4	.	.	PUNCT
ijpds-3583	111	1	15	15	NUM
ijpds-3583	111	2	june	june	PROPN
ijpds-3583	111	3	2019	2019	NUM
ijpds-3583	111	4	[	[	X
ijpds-3583	111	5	cited	cite	VERB
ijpds-3583	111	6	28	28	NUM
ijpds-3583	111	7	july	july	PROPN
ijpds-3583	111	8	2022	2022	NUM
ijpds-3583	111	9	]	]	PUNCT
ijpds-3583	111	10	;	;	PUNCT
ijpds-3583	111	11	9(3	9(3	NUM
ijpds-3583	111	12	-	-	SYM
ijpds-3583	111	13	s	s	PART
ijpds-3583	111	14	):	):	PUNCT
ijpds-3583	111	15	62	62	NUM
ijpds-3583	111	16	8	8	NUM
ijpds-3583	111	17	.	.	PUNCT
ijpds-3583	112	1	available	available	ADJ
ijpds-3583	112	2	from	from	ADP
ijpds-3583	112	3	:	:	PUNCT
ijpds-3583	112	4	http://jddtonline.info/index.php/jddt/article/view/2756	http://jddtonline.info/index.php/jddt/article/view/2756	PROPN
ijpds-3583	112	5	9	9	NUM
ijpds-3583	112	6	.	.	X
ijpds-3583	112	7	ich	ich	NOUN
ijpds-3583	112	8	q2a	q2a	PROPN
ijpds-3583	112	9	text	text	NOUN
ijpds-3583	112	10	on	on	ADP
ijpds-3583	112	11	validation	validation	NOUN
ijpds-3583	112	12	of	of	ADP
ijpds-3583	112	13	analytical	analytical	ADJ
ijpds-3583	112	14	procedure	procedure	NOUN
ijpds-3583	112	15	,	,	PUNCT
ijpds-3583	112	16	international	international	ADJ
ijpds-3583	112	17	conference	conference	NOUN
ijpds-3583	112	18	on	on	ADP
ijpds-3583	112	19	harmonisation	harmonisation	NOUN
ijpds-3583	112	20	.	.	PUNCT
ijpds-3583	113	1	tripartite	tripartite	ADJ
ijpds-3583	113	2	guideline	guideline	NOUN
ijpds-3583	113	3	.	.	PUNCT
ijpds-3583	114	1	1994	1994	NUM
ijpds-3583	114	2	;	;	PUNCT
ijpds-3583	115	1	1	1	NUM
ijpds-3583	115	2	-	-	SYM
ijpds-3583	115	3	5	5	NUM
ijpds-3583	115	4	.	.	NOUN
ijpds-3583	115	5	10	10	NUM
ijpds-3583	115	6	.	.	PUNCT
ijpds-3583	115	7	bekett	bekett	PROPN
ijpds-3583	115	8	ah	ah	INTJ
ijpds-3583	115	9	,	,	PUNCT
ijpds-3583	115	10	stenlake	stenlake	PROPN
ijpds-3583	115	11	jb	jb	PROPN
ijpds-3583	115	12	,	,	PUNCT
ijpds-3583	115	13	practical	practical	ADJ
ijpds-3583	115	14	pharmaceutical	pharmaceutical	ADJ
ijpds-3583	115	15	chemistry	chemistry	NOUN
ijpds-3583	115	16	,	,	PUNCT
ijpds-3583	115	17	cbs	cbs	PROPN
ijpds-3583	115	18	publisher	publisher	NOUN
ijpds-3583	115	19	and	and	CCONJ
ijpds-3583	115	20	distributers	distributer	NOUN
ijpds-3583	115	21	,	,	PUNCT
ijpds-3583	115	22	new	new	ADJ
ijpds-3583	115	23	delhi	delhi	PROPN
ijpds-3583	115	24	,	,	PUNCT
ijpds-3583	115	25	india	india	PROPN
ijpds-3583	115	26	part	part	NOUN
ijpds-3583	115	27	2	2	NUM
ijpds-3583	115	28	2002	2002	NUM
ijpds-3583	115	29	;	;	PUNCT
ijpds-3583	115	30	237	237	NUM
ijpds-3583	115	31	275	275	NUM
ijpds-3583	115	32	.	.	PUNCT
ijpds-3583	116	1	11	11	NUM
ijpds-3583	116	2	.	.	X
ijpds-3583	117	1	ich	ich	NOUN
ijpds-3583	117	2	q2b	q2b	NOUN
ijpds-3583	117	3	text	text	VERB
ijpds-3583	117	4	on	on	ADP
ijpds-3583	117	5	validation	validation	NOUN
ijpds-3583	117	6	of	of	ADP
ijpds-3583	117	7	analytical	analytical	ADJ
ijpds-3583	117	8	procedure	procedure	NOUN
ijpds-3583	117	9	,	,	PUNCT
ijpds-3583	117	10	international	international	ADJ
ijpds-3583	117	11	conference	conference	NOUN
ijpds-3583	117	12	on	on	ADP
ijpds-3583	117	13	harmonisation	harmonisation	NOUN
ijpds-3583	117	14	.	.	PUNCT
ijpds-3583	118	1	tripartite	tripartite	ADJ
ijpds-3583	118	2	guideline	guideline	NOUN
ijpds-3583	118	3	.	.	PUNCT
ijpds-3583	119	1	1994	1994	NUM
ijpds-3583	119	2	;	;	PUNCT
ijpds-3583	119	3	1	1	NUM
ijpds-3583	119	4	10	10	NUM
ijpds-3583	119	5	.	.	PUNCT
ijpds-3583	120	1	how	how	SCONJ
ijpds-3583	120	2	to	to	PART
ijpds-3583	120	3	cite	cite	VERB
ijpds-3583	120	4	this	this	DET
ijpds-3583	120	5	article	article	NOUN
ijpds-3583	120	6	:	:	PUNCT
ijpds-3583	120	7	shaikhmulani	shaikhmulani	PROPN
ijpds-3583	120	8	hi	hi	PROPN
ijpds-3583	120	9	,	,	PUNCT
ijpds-3583	120	10	tamboli	tamboli	PROPN
ijpds-3583	120	11	am	be	AUX
ijpds-3583	120	12	,	,	PUNCT
ijpds-3583	120	13	tambili	tambili	ADJ
ijpds-3583	120	14	na	na	PROPN
ijpds-3583	120	15	,	,	PUNCT
ijpds-3583	120	16	kshirsagar	kshirsagar	PROPN
ijpds-3583	120	17	rt	rt	PROPN
ijpds-3583	120	18	,	,	PUNCT
ijpds-3583	120	19	suryawanshi	suryawanshi	PROPN
ijpds-3583	120	20	ht	ht	PROPN
ijpds-3583	120	21	,	,	PUNCT
ijpds-3583	120	22	khandare	khandare	PROPN
ijpds-3583	120	23	o.	o.	PROPN
ijpds-3583	120	24	rp	rp	PROPN
ijpds-3583	120	25	-	-	PUNCT
ijpds-3583	120	26	hplc	hplc	NOUN
ijpds-3583	120	27	method	method	NOUN
ijpds-3583	120	28	development	development	NOUN
ijpds-3583	120	29	and	and	CCONJ
ijpds-3583	120	30	validation	validation	NOUN
ijpds-3583	120	31	for	for	ADP
ijpds-3583	120	32	simultaneous	simultaneous	ADJ
ijpds-3583	120	33	estimation	estimation	NOUN
ijpds-3583	120	34	of	of	ADP
ijpds-3583	120	35	benidipine	benidipine	NOUN
ijpds-3583	120	36	hydrochloride	hydrochloride	NOUN
ijpds-3583	120	37	and	and	CCONJ
ijpds-3583	120	38	chlorthalidone	chlorthalidone	NOUN
ijpds-3583	120	39	in	in	ADP
ijpds-3583	120	40	pharmaceutical	pharmaceutical	ADJ
ijpds-3583	120	41	dosage	dosage	NOUN
ijpds-3583	120	42	form	form	NOUN
ijpds-3583	120	43	.	.	PUNCT
ijpds-3583	121	1	indian	indian	PROPN
ijpds-3583	121	2	j	j	PROPN
ijpds-3583	121	3	pharm	pharm	PROPN
ijpds-3583	121	4	drug	drug	PROPN
ijpds-3583	121	5	studies	study	NOUN
ijpds-3583	121	6	.	.	PUNCT
ijpds-3583	122	1	2022	2022	NUM
ijpds-3583	122	2	:	:	PUNCT
ijpds-3583	122	3	1(3	1(3	NUM
ijpds-3583	122	4	)	)	PUNCT
ijpds-3583	122	5	102	102	NUM
ijpds-3583	122	6	-	-	SYM
ijpds-3583	122	7	107	107	NUM
ijpds-3583	122	8	.	.	PUNCT
ijpds-3583	123	1	funding	funding	NOUN
ijpds-3583	123	2	:	:	PUNCT
ijpds-3583	123	3	none	none	NOUN
ijpds-3583	123	4	conflict	conflict	NOUN
ijpds-3583	123	5	of	of	ADP
ijpds-3583	123	6	interest	interest	NOUN
ijpds-3583	123	7	:	:	PUNCT
ijpds-3583	123	8	none	none	NOUN
ijpds-3583	123	9	stated	state	VERB
ijpds-3583	123	10	fig	fig	NOUN
ijpds-3583	123	11	.	.	PUNCT
ijpds-3583	124	1	6	6	NUM
ijpds-3583	124	2	chromatogram	chromatogram	NOUN
ijpds-3583	124	3	of	of	ADP
ijpds-3583	124	4	80	80	NUM
ijpds-3583	124	5	%	%	NOUN
ijpds-3583	124	6	accuracy	accuracy	NOUN
ijpds-3583	124	7	fig	fig	NOUN
ijpds-3583	124	8	.	.	PUNCT
ijpds-3583	125	1	7	7	NUM
ijpds-3583	125	2	chromatogram	chromatogram	NOUN
ijpds-3583	125	3	of	of	ADP
ijpds-3583	125	4	100	100	NUM
ijpds-3583	125	5	%	%	NOUN
ijpds-3583	125	6	accuracy	accuracy	NOUN
ijpds-3583	125	7	.	.	PUNCT
ijpds-3583	126	1	fig	fig	NOUN
ijpds-3583	126	2	.	.	PUNCT
ijpds-3583	127	1	8	8	NUM
ijpds-3583	127	2	chromatogram	chromatogram	NOUN
ijpds-3583	127	3	of	of	ADP
ijpds-3583	127	4	120	120	NUM
ijpds-3583	127	5	%	%	NOUN
ijpds-3583	127	6	accuracy	accuracy	NOUN
ijpds-3583	127	7	.	.	PUNCT
ijpds-3583	128	1	https://engo.drugbank.com/drug/db09231	https://engo.drugbank.com/drug/db09231	X
ijpds-3583	129	1	https://en.m.wikipedia.org/wiki/chlorthalidone	https://en.m.wikipedia.org/wiki/chlorthalidone	PROPN
ijpds-3583	129	2	http://dx.doi.org/10.20959/wjpr201710-9417	http://dx.doi.org/10.20959/wjpr201710-9417	INTJ
ijpds-3583	129	3	http://dx.doi.org/10.20959/wjpr201710-9417	http://dx.doi.org/10.20959/wjpr201710-9417	INTJ